KCC2 plays a crucial role during the maturation of spinal neurons by regulating the expression of the GlyR alpha subunit and gephyrin by Schumacher, Stefanie Birgitta
Inauguraldissertation zur Erlangung der Doktorwürde 
der Naturwissenschaftlich-Mathematischen Gesamtfakultät 
der Ruprecht-Karls-Universität Heidelberg 
 
 
 
 
 
 
 
 
 
KCC2 Plays a Crucial Role  
during the Maturation of Spinal  
Neurons by Regulating the  
Expression of the GlyR Alpha1 Subunit 
and Gephyrin 
 
 
 
 
 
 
 
 
 
 
vorgelegt von 
Diplom-Biologe Stefanie Birgitta Schumacher 
aus Bretten 
 
Tag der mündlichen Prüfung:   
  
 
  
 
 
 
 
 
 
KCC2 Plays a Crucial Role  
during the Maturation of Spinal  
Neurons by Regulating the  
Expression of the GlyR Alpha1 
Subunit and Gephyrin 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Referees: Prof. Dr. Hilmar Bading 
 Prof. Dr. Joachim Kirsch 
 
  
 
 Acknowledgements 
 
First, I would like to thank Prof. Dr. Joachim Kirsch who gave me the opportunity to take part in 
his research group and who provided the topic. He always supported and motivated me with great 
patience and impressive knowledge. I was able to work independently and to experience a broad range 
of methods. I also want to thank Prof. Dr. Hilmar Bading for being my first referee. Whenever I 
needed his help, he took the time and quickly answered all my issues. 
 
Thanks to all the people of the fourth floor for support, advice and reagents whenever I needed 
them and for the friendly atmosphere. 
 
Special thanks to Jochen Kuhse who always was open to my questions and problems. He took the 
important critical part and had great ideas for my work. A special thank to Nicolai who was very dedi-
cated and helped a lot during his practical course and who made a few experiments used for this thesis. 
Thanks to Christoph for soccer stickers, critical challenge and for informing me about every single out 
coming KCC2 and GlyR article. Thanks to Susanne for great help and even greater ideas in solving 
problems. I also would like to thank Valandis for tireless trials of measuring cells and for long and 
illuminating discussions. Big thanks to Kathrin who brightened every day in the lab and for her in-
credible friendship. Special thanks to Rita for preparing and culturing the SNs. I also would like to 
thank Barbara for office stuff, her great humour, funny and serious conversations and everything else. 
Many, many thanks to Andrea, without her I would not have succeeded. Thanks for countless proto-
cols, advices, talks, for providing HCNs and SNs and for facilitating my life in the lab so much! 
 
Many special thanks to my parents and my brothers for constant support and for standing by my 
side during my whole life! 
 
I would like to express my deepest thanks to Christian for lightening up every day, for consolation, 
great support, for making me laugh and for simply being in my life. 
 
 
  
 
 Summary 
In spinal cord and brain stem, the GlyR is the major receptor type to mediate inhibitory synaptic 
transmission. Together with the GlyRb subunit, the GlyRa1 subunit forms the adult form of the recep-
tor. Activation of the pentameric GlyR by glycine results in an increased permeability of the GlyR 
channel for chloride. In juvenile stages, the cell is depolarized whereas adult neurons experience a 
hyperpolarization. Not least, the activity of KCC2, changing the intracellular chloride level from a 
high to a low adult state, contributes considerably to the maturation of the neurons. 
In this thesis, the approximate time point of the switch to occur in vitro could be determined to 
div 14 via mRNA expression studies of the distinct GlyR subunits. The obtained mRNA data also 
indicate that the GlyRb subunit exhibits the highest RNA expression whereas GlyRa1 expression is 
even lower than that of GlyRa2. Taken together, the results suggest that adult neurons as well as juve-
nile neurons still express heteromeric α2β and/or homomeric α2 receptors. 
Strychnine application to the SN cultures resulted in a down regulation of KCC2 expression in a 
dose-dependent manner at div 14. This finding indicates that the activity of the GlyR may regulate the 
expression of KCC2 to some extent. Subsequent treatments with Ca2+ channel blockers and Ca2+ che-
lators revealed a role for Ca2+ to destabilize the KCC2 complex. Although suppression of the entire 
synaptic transmission in the culture by TTX application as well as catching all free Ca2+ ions also re-
duce KCC2 expression, the latter seems not to be dependent on Ca2+ influx via L-type channels. How-
ever, KCC2 expression either depends on Ca2+ being present within the cell or Ca2+ influx through 
another type of Ca-channel than L-type. 
To clarify the role of KCC2 in the GlyR subunit switch, its expression successfully was down 
regulated upon transduction by a silencing shRNA construct. Immunoblot and localization of immuno-
reactivities reveal a decrease in the expression of the adult GlyRa1 subunit following KCC2 knock-
down. The expression of gephyrin is affected as well. In the main, no additionally investigated synap-
tic proteins are concerned. Therefore, the neurons are supposed to remain in a juvenile state in terms 
of the GlyR when KCC2 is not expressed properly. The question arising is, whether the pure presence 
or the activity of KCC2 is responsible for the correct GlyRa1 expression. It also remains unclear 
whether knockdown of KCC2 affects GlyRa1 expression and hence gephyrin expression, the other 
way around or whether even both proteins directly are affected by loss of KCC2. 
I suggest that loss of KCC2 impairs the expression of the scaffolding protein gephyrin via un-
known cytoskeletal mechanisms or signalling pathways. The absence of gephyrin in turn directs loss 
of the adult GlyR consisting of GlyRa1 and GlyRb. This loss might result from either down regulation 
of GlyRa1 expression or removal of the adult receptor from the membrane and subsequent degrada-
tion. 
 
 
 Zusammenfassung 
Im Rückenmark und im Hirnstamm ist hauptsächlich der Glyzin Rezeptor (GlyR) als inhibitorisch 
agierender Rezeptortyp exprimiert. Die GlyRb und die GlyRa1 Untereinheiten formen zusammen den 
adulten Rezeptor. Wird der pentamere GlyR durch Glyzin aktiviert, erhöht sich seine Permeabilität für 
Chlorid, wodurch im Adultstadium eine Hyperpolarisation der postsynaptischen Membran hervorgeru-
fen wird. Im Jugendstadium dagegen erfährt die Zelle eine Depolarisation und somit eine exzitatori-
sche Antwort. Durch die drastische Verringerung des hohen, intrazellulären Chloridlevels trägt die 
Aktivität von KCC2 nicht zuletzt auch zur Reifung der Neurone bei. 
In dieser Arbeit konnte ein etwaiger Zeitpunkt des GlyR Untereinheiten Switch determiniert wer-
den. In vitro Daten aus mRNA Expressionsstudien der unterschiedlichen Untereinheiten zufolge findet 
der Switch um den Zeitpunkt div 14 statt. Aus den besagten Daten geht auch hervor, dass die GlyRb 
Untereinheit die höchste mRNA-Expression aufweist, wogegen das GlyRa1-Expressionslevel sogar 
unter dem von GlyRa2 liegt. Zusammenfassend lässt sich aussagen, dass auch reife Neurone aus dem 
Rückenmark noch heteromere α2β und/oder homomere α2 Rezeptoren exprimieren. 
Behandelt man die SN Kulturen mit Strychnin, tritt eine dosisabhängige Abnahme der KCC2-
Expression an div 14 auf. Daraus kann man schließen, dass die KCC2-Expression in gewissem Maße 
durch die Aktivität des GlyRs reguliert wird. Anschließend wurden die Zellen mit Ca2+-Kanal Bloc-
kern und Ca2+-Chelatbildnern behandelt. Daraus geht hervor, dass Ca2+ möglicherweise dazu imstande 
ist, den KCC2-Komplex, der nur als Tetramer aktiv ist, zu destabilisieren. Obwohl die Inhibierung der 
gesamten synaptischen Transmission der Kultur durch TTX als auch das Komplexieren aller freier Ca-
Ionen zu einer verminderten KCC2-Expression führt, scheint letzteres nicht vom Ca2+-Einstrom durch 
L-Typ Kanäle abhängig zu sein. Dennoch hängt die KCC2 Expression entweder von freien Ca2+-Ionen 
innerhalb der Zelle oder von einströmendem Ca2+ durch andere Kanäle ab. 
Um die Rolle von KCC2 im GlyR Untereinheiten Switch zu klären, wurden die Neurone mit ei-
nem shRNA Konstrukt transduziert, das die Expression von KCC2 fast komplett still legt. Eine daraus 
folgende Verminderung der adulten GlyRa1 Untereinheiten-Expression konnte in Immunoblots und 
Immunfärbungen aufgezeigt werden. Ebenso betroffen von dem KCC2 Knockdown war Gephyrin, 
welches den adulten GlyR am Zytoskelett verankert. Im Großen und Ganzen wurden alle anderen un-
tersuchten synaptischen Proteine nicht durch den KCC2 Knockdown beeinträchtigt. Daraus folgt, dass 
die Zellen, im Bezug auf den GlyR, in einem jugendlichen Stadium verharren, wenn KCC2 nicht im 
richtigen Ausmaß exprimiert wird. Daraus resultiert die Frage, ob die bloße Anwesenheit von KCC2 
oder seine Aktivität verantwortlich für die korrekte GlyRa1-Expression ist. Es bleibt auch unklar, ob 
der Knockdown von KCC2 die GlyRa1 Untereinheiten-Expression direkt und daraus folgend die 
Gephyrin-Expression beeinträchtigt oder umgekehrt oder ob sogar beide Proteine direkt durch den 
Verlust der KCC2-Expression betroffen sind. 
Meine Vermutung ist, dass der Verlust an KCC2 das gerüstbildende Protein Gephyrin über bisher 
unbekannte Zytoskelett-Verbindungen oder Signalwege in Mitleidenschaft zieht. Der Verlust an 
 
 Gephyrin wiederum führt zu einer Verminderung des adulten GlyRs, bestehend aus GlyRa1 und 
GlyRb. Diese Verminderung könnte entweder aus der Abnahme der GlyRa1-Expression oder aus der 
Entfernung des GlyRs aus der Membran und anschließender Degradierung resultieren. 
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 1. Introduction 
1.1. The spinal cord 
1.1.1. Composition of the adult spinal cord 
Extending from the Medulla oblongata, the spinal cord is a long, thin, tubular bundle of nervous 
tissue and support cells. Together with the brain, it represents the central nervous system (CNS). The 
spinal cord is protected by the enclosing vertebral column. In mammals, the spinal cord ranges from 
the Foramen magnum (cranium) to backmost lumbar vertebrae. This is because the backbone is devel-
oping faster than the spinal cord and thus the spinal cord’s longitudinal growth drops behind that of 
the backbone. This phenomenon is called Ascensus medullae spinalis. Therefore, the roots of the spi-
nal nerves have to cover a more and more elongated distance in caudal direction because they still 
break through their original intervertebral foramen. Thus, only the spinal nerve roots proceed within 
the vertebral canal underneath the cone-shaped spinal cord ending. The spinal cord is as well as the 
brain surrounded by liquor. In terms of spinal meninges, three of them are distinguished: the external 
Dura mater, the medial Arachnoidea and the internal Pia mater. The spinal cord track has two swell-
ings: one at the Intumescentia cervicalis and another one at the Intumescentia lumbosacralis. In these 
regions, spinal nerves innervating the fore and hind limbs, which require more neurons than e.g. the 
trunk, emerge from the vertebral canal.  
 
 
Figure 1: Structures of the spinal cord in cross-section  
Source: http://www.wikipedia.de 
Structures of the gray matter: 
1. ventral horn 
2. dorsal horn 
3. Commissura grisea 
Structures of the white matter: 
4. ventral funiculus 
5. lateral funiculus 
6. dorsal funiculus 
7. Commissura alba ventralis  
8. Fissura mediana ventralis 
9. Sulcus medianus dorsalis 
Other structures: 
10. Canalis centralis 
11. ventral root 
12. dorsal root  
13. Ganglion sensorium nervi spinalis 
 
On the ventral side of the spinal cord, the Fissura mediana ventralis is proceeding whereas dor-
sally another groove, the Sulcus medianus posterior is extending (Figure 1). On both sides, three 
strands are distinguishable: the ventral funiculus, the dorsal funiculus and in between them, the lateral 
funiculus of the spinal cord (Figure 1). Between the dorsal and the lateral funiculus, the dorsal root is 
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passing through whereas the ventral root escapes between the lateral and the ventral funiculus. The 
spinal nerve roots meet on the level of the intervertebral foramen where they form the spinal nerves. 
According to the spinal nerve leaving points, the spinal cord is structured in five sections. The cer-
vical part contains eight segments (C1-8) in mammals, whereas the thoracic part consists of 12 seg-
ments (Th1-12). The lumbar and the sacral part exhibit 5 segments respectively (L1-5 and S1-5) and 
the coccygeal part has 1-5 segments (grown together in some degree).  
Regarding the longitudinal section of the fetal spinal cord, three layers are distinguishable. The 
one lying next to the Canalis centralis is called ventricular germinal zone and gives rise to neuro-
blasts, glioblasts and at the end ependymal cells. The intermediate zone is forming the gray matter 
whereas the white matter arises from the marginal zone. 
Occupying cell bodies, the gray matter of the spinal cord has the shape of a butterfly. The ventral, 
broader part is called the ventral horn (Cornu ventrale). The dorsal part is narrower and called the 
dorsal horn (Cornu dorsale). In the field of the thoracic and lumbar part of the spinal cord, another 
smaller lateral horn is appearing (Cornu laterale, Figure 2, green). The “butterfly wings” of the gray 
matter are cross-linked by the Commissura grisea (Figure 1). The Canalis centralis filled with liquor 
is located in the middle of this commissure (Figure 1 and Figure 2). The gray matter is further organ-
ized into ten layers, the so-called Laminae (Figure 2). Laminae I-VII are located in the dorsal horn 
whereas Laminae VIII and IX reside in the ventral horn, Laminae X at last is forming the mentioned 
cross linkage (Figure 2). In terms of function, several nuclei can be distinguished in the spinal cord. 
The Nucleus intermediolateralis is the origin of the sympathetic nerve fibres in thoracic and lumbar 
spinal cord. The motor nuclei columns located in the ventral horn represent the origin of the motor 
fibres (Figure 2). 
The dorsal horn is supplied with sensitive input coming via the dorsal, sensitive root of the spinal 
nerve from the periphery. The cell bodies of the sensitive nerve cells being pseudounipolar are located 
beyond the spinal cord within the dorsal root ganglion. Their axons enter the dorsal horn via the dorsal 
root. In the dorsal horn, they either are switched to a second neuron or directly project to the brain via 
special tracks within the white matter. The motor neurons reside within the ventral horn of the spinal 
cord. The axons of the motor neurons forming the ventral root are sent to the muscles and neuromus-
cular spindles. The lateral horn in the thoracic and lumbar part (Figure 2) of the spinal cord is formed 
by the cell bodies of vegetative neurons and therefore it belongs to the sympathetic nervous system. 
The efferent fibres of the vegetative neurons leave the spinal cord via the ventral root and project to 
the sympathetic trunk where they are partially switched to a second neuron. If not, they are sent to the 
prevertebral ganglia to be switched there. Coming from the periphery, sympathetic afferent tracks 
project to the lateral horn. In the sacral part, cell bodies of parasympathetic neurons are located at the 
same position but do not form a lateral horn. 
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Figure 2: Laminae and nuclei of the spinal cord 
in cross section. The gray matter corresponds to 
the thoracic and lumbar region of the spinal cord. 
Source: http://www.wikipedia.de 
 
The mentioned tracks run within the white matter of the spinal cord. The afferent fibres (mostly 
sensitive) project to the brain whereas the efferent fibres (mostly motor) originate in the brain. The 
white colour arises from the myelination of the axons. Two important afferent tracks forming the dor-
sal fasciculus (Figure 3) whose cell bodies are located in the spinal ganglia are Fasciculus cuneatus 
and Fasciculus gracilis. They direct information about smooth touches and deep sensibility to the 
Medulla oblongata (afterbrain). There the initial switch appears in the accordant nuclei. Right after 
switching, the fibres cross to the other side. Information about rough pressure, temperature and pain 
(protopathic sensibility) is conducted by the Tractus spinothalamicus or anterolateral funiculus (Figure 
3) from the dorsal horn to the Thalamus. Proprioceptive impulses about position and attitude of joints, 
muscles and tendons are conducted by the Tractus spinocerebellaris (Figure 3) arising from the Nu-
cleus dorsalis in the dorsal horn and ending in the cerebellum. This track remains uncrossed. 
One of the important efferent tracks is the corticospinal funiculus (Tractus corticospinalis, Figure 
3) spanning from the motor cortex of the external granular layer of the cerebral cortex to the ventral 
horn. Tracks not belonging to the latter funiculus are denoted as extrapyramidal tracks. 
The most important inhibitory neurotransmitter in the spinal cord is glycine. Interneurons and 
Renshaw cells are glycinergic, releasing glycine at their synaptic endings. The released glycine opens 
ligand-gated ion channels of the downstream lying neuron and thus lowers its activity. In the spinal 
cord, the glycinergic neurons inhibit motoneurons of the ventral horn. This process diminishes the 
activity of muscles innervated by the motoneurons. Strychnine is a potent antagonist of the GlyR and 
is able to abate the force of glycine. Abolition of the inhibition directs increased muscle activity caus-
ing life-threatening spasms. 
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Figure 3: Afferent and efferent tracks of the white matter. 
Source: http://www.wikipedia.de 
 
Somatotopic arrangement: 
S: fibres from the sacral part 
L: fibres from the lumbar part 
TH: fibres from the thoracic part 
C: fibres from the cervical part 
Motor tracks (efferent, red): 
5. pyramidal funiculus 
a. Tractus corticospinalis lateralis 
b. Tractus corticospinalis anterior 
6. extrasynaptic funiculi 
a. Tractus rubrospinalis 
b. Tractus reticulospinalis 
c. Tractus vestibulospinalis 
d. Tractus olivospinalis 
Sensitive tracks (afferent, blue): 
1. dorsal fasciculus 
a. Fasciculus gracilis 
b. Fasciculus cuneatus 
2. spinocerebellar tracts 
a. Tractus spinocereballaris posterior 
b. Tractus spinocerebellaris anterior 
3. sensitive anterolateral tracts 
a. Tractus spinothalamicus lateralis 
b. Tractus spinothalamicus anterior 
4. Tractus spinoolivaris 
 
Schematically, postsynaptic inhibition is functionally excitatory in the spinal cord at about one 
week before birth and inhibitory at about one week after birth. During this critical time window, path-
ways descending from the brain stem reach the lumbar cord. 
 
1.1.2. Development of the neural tube 
After gastrulation, the notochord induces the dorsomedial part of the embryonic ectoderm to form 
the thick and flat neural plate (Figure 4A) by secreting growth factors (e.g. sonic hedgehog). There-
fore, BMP signals have to be repressed. Cells receiving BMP develop into epidermal cells. Chordin 
and noggin, both shown to bind directly to BMP, are responsible for the active repression of BMP (Liu 
and Niswander 2005). Inducing a neural fate and being created and emitted by the Spemann organiser, 
chordin and noggin typically are expressed on the dorsal side of the embryo whereas BMPs rather are 
expressed ventrally. BMPs 13-15 e.g. are able to prevent cells from a neural fate. Thus, suppression of 
BMP signalling on the dorsal side of the embryo is important to allow formation of neural tissue 
though also other pathways contribute to this process. Recent studies reveal that FGF (fibroblast 
growth factor) signalling also is crucial for neural induction (Liu and Niswander 2005). Thereby, FGF 
is thought to sensitize the tissue to respond to the BMP antagonists. FGF signalling is further shown to 
suppress BMP4 and BMP7 expression. Neural fate induction is also promoted by IGF (insulin-like 
growth factor). 
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At the border between the neuroectoderm and the non-neural ectoderm, a multiprogenitor popula-
tion is generated. This structure, the neural crest, gives rise to a couple of different migratory cell types 
forming peripheral neurons, glial cells, connective tissue, bone, secretory cells, melanocytes and the 
outflow tract of the heart (Gammill and Bronner-Fraser 2003). Applied to naive neural tissue explants, 
recombinant BMP is able to induce neural crest tissue. In the BMP mutants swirl (swr or bmp2b), 
snailhouse (snh or bmp7) and somitobun (sbn or smad5) the precursors for trunk neural crest cells 
refrained from forming (Liu and Niswander 2005). Additional to BMPs, also Wnts, FGFs and Notch 
seem to be able to induce neural crest formation. Thus, a ‘two signal model’ requiring both, BMP and 
Wnt signalling for neural crest formation, has been postulated. FGF seems to play a role in regulating 
MSX1 expression, which in turn also regulates BMP signalling. Further roles for BMPs are forward-
ing neural crest cell migration, directing neural crest differentiation and arrangement of neural crest 
cell apoptosis in the hindbrain (Liu and Niswander 2005). Wnt proteins are also involved in migration, 
proliferation and differentiation of neural crest cells. 
In the further development of neurulation, the neural groove is formed by dropping of the neural 
plate triggered by the generation of a ventrally localized hinge point called floor plate (Figure 4A). 
The final tube is formed by fusion of the lateral edges of the neural plate and afterwards is segregated 
from the non-neural epithelium. The neural tube represents the complete CNS anlage. Its lumen be-
comes the ventricular system of the brain and the spinal cord. At the dorsal midline of the tube, a new 
organizing centre producing BMPs, namely the roof plate, is formed. Secreting BMPs, the ectoderm 
and the roof plate have an important role in dorsoventral patterning of the neural tube (Figure 4B). The 
roof plate additionally expresses Bmp2, Bmp4, Bmp7, Gdf7, activin and dorsalin mRNA. Therefore, 
BMPs and members of the TGF family are responsible for dorsalizing the neural tube (Liu and 
Niswander 2005). A ligand gradient of BMPs and TGF members with higher levels corresponding to 
a more dorsal fate seems to be crucial for the patterning. Expressed in the floor plate, Shh also has an 
important role in patterning the ventral spinal cord. Deprivation of Shh expression ends in a loss of the 
most ventral cell types such as motor neurons or ventral interneurons. Furthermore, a couple of BMP 
antagonists (see above) is expressed in the axial and paraxial mesoderm flanking the neural tube. Dor-
sally, sensory interneurons, commissural neurons and neural crest cells develop whereas motoneurons 
and some interneurons arise ventrally. The first, rather rough determination occurs by expression of 
homeobox genes of the Pax and Nkx family. Dorsal progenitors exhibit Pax3 and Pax7 expression 
activated by BMPs. Being repressed in the dorsal spinal cord by BMPs, Pax6 is expressed in the ven-
tral intermediate region. Nkx2, in contrast, is expressed by ventral progenitors adjacent to the floor 
plate (Figure 4B). Further subdivisions are achieved by expression of different basic helix-loop-helix 
(bHLH) and homeodomain transcription factors also tightly being regulated by BMPs. The most dor-
sal region is defined by Math1 expression, less dorsal cells express neurogenin 1 and 2 (NGN1/2) and 
Mash respectively. According to the transcription factor, being expressed in the cells, they differenti-
ate into dorsal interneurons, ventral interneurons or motoneurons. 
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Patterning of the spinal cord is closely connected with proliferation. Secreted Wnt proteins as well 
as BMPs seem to be necessary and sufficient for cell proliferation in the dorsal spinal cord. Possibly, 
BMPs are thereby involved in the regulation of Wnt signalling. 
 
 
Left and right panel:
Liu and Niswander 2005
Figure 4: A, formation of the neural tube by neurulation. Green part: floor plate, purple part: roof plate. B, dorsoventral 
patterning of the spinal cord. The neural progenitor cells are first divided into broad dorsoventral domains by the differential 
expression of Pax homeobox genes regulated by BMPs. The spinal cord is further subdivided by the expression of basic 
helix–loop–helix (bHLH) family and homeodomain transcription factors. This process is also tightly regulated by BMP 
signalling. dI: dorsal interneurons, v: ventral interneurons, MN: motoneurons. 
 
1.2. The Glycine receptor 
1.2.1. GlyR assembly and signalling 
In the adult spinal cord, brainstem and retina, the inhibitory neurotransmission is mainly mediated 
by the glycine receptor (GlyR). Found in the presynapse, GlyRs modulate neurotransmitter release. 
Postsynaptically, the amino acid glycine acts as the major agonist beside -alanine and taurine. A 
high-affinity competitive antagonist is strychnine. The glycine and the strychnine binding sites indeed 
overlap but are not identical. In addition, cyclothiazide (Zhang et al. 2007) and caffeine (Duan et al. 
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2009) have recently been shown to block the GlyR. The activity of the GlyR can also be modulated by 
picrotoxin, zinc, alcohol, cocaine and anesthetics (Leite and Cascio 2001). To maximally activate a 
homomeric GlyR, three bound glycine molecules are sufficient (Lewis et al. 2003, Beato et al. 2004). 
Two related subunits named α (GlyRa, 48 kDa) and  (GlyRb, 58 kDa) are known. Currently, four 
different vertebrate isoforms of the GlyR alpha genes (GlyRa1-4) and the single GlyR beta gene are 
identified (Lynch 2004). The GlyR  subunit shares 47% amino acid sequence homology with the 
α1 subunit whereas the α subunits share more than 90% amino acid sequence homology with each 
other. Each of the subunits contains a large extracellular ligand-binding domain at the N-terminus, 
mainly consisting of -sheets as well as four α-helical transmembrane domains (TM1-4, Figure 5) and 
a short extracellular C-Terminus. The -sheets are connected by flexible loops. TM3 and TM4 are 
connected by a large, among ligand-binding ion channels poorly conserved, intracellular domain hold-
ing phosphorylation sites and other sites for interaction with cytoplasmic factors. Belonging to the 
Cys-loop ion channel superfamily, the GlyR owns a disulfide bond-mediated loop in the mentioned N-
terminal domain. The amphipathic TM2 domain is responsible for the formation of the central water-
filled channel pore. The unusual large cytoplasmic loop (130 residues) between TM3 and TM4 of the 
GlyRb subunit includes a gephyrin binding domain consisting of an 18-amino-acid motif (Kim et al. 
2006, Meyer et al. 1995, Sola et al. 2004). Interacting with GlyRb, gephyrin might serve as a connec-
tion point between the GlyR and the actin-filaments via profilin and Mena/VASP. The pentameric 
GlyR is believed to consist of two α1 and three  subunits in its adult state (Grudzinska et al. 2005). 
The juvenile form of the GlyR is either a homo-oligomer built of only α2 subunits or a hetero-
oligomer composed of α2 and  subunits. The homo-oligomer is not thought to bind directly to gephy-
rin. Although forming homomeric GlyRs in recombinant expression systems, α1, α3 and α4 GlyR 
homo-oligomers weakly are expressed in adult neurons. α2 homo-oligomers, in contrast, are abun-
dantly expressed in embryonic neurons. 
The high intracellular chloride level of embryonic or rather neonatal neurons generates an out-
wardly directed chloride flux toward the Cl- equilibrium potential. The outcome is a depolarisation of 
the postsynaptic neuron, when the GlyR is activated. Hence, Ca2+ fluxes through voltage-gated Ca2+-
channels, leading to intracellular signalling, are induced. Joachim Kirsch and Heinrich Betz could 
show that the mentioned Ca2+-signal is crucial for the formation and maintenance of the GlyR clusters 
and that GlyR activity and Ca2+-signalling are associated in juvenile spinal neurons (Kirsch and Betz 
1998). Still little is known about GlyR mediated gene and protein expression. Raphael Blüm could 
recently reveal that the juvenile GlyRa2 subunit may bind eEF1A, calcineurin and p70S6 kinase 
(Bluem et al. 2007). Being crucial for protein synthesis and actin bundling, eEF1A might act as a con-
nection partner between the α2 subunit and actin-filaments, which could be an explanation for GlyRa2 
clusters in young neurons. 
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Activation of the adult GlyR generates a hyperpolarisation of the postsynaptic cell evoked by chlo-
ride influx into the cell resulting in an inhibition of the postsynaptic neuron (Betz and Laube 2006, 
Kirsch 2006). 
 
Figure 5: GlyR assembly. 
Pentameric GlyR with its three functional do-
mains: the extracellular ligand-binding, the 
transmembrane and the cytoplasmic (loop) 
domains. Interaction with the gephyrin trimer is 
depicted. 
 Fritschy et al. 2008
 
1.2.2. Anchoring, trafficking and motility of the GlyR 
Additional to the GlyR subunits, Pfeiffer could purify a third protein of 93 kDa in size (Pfeiffer et 
al. 1982). This peripheral membrane protein named gephyrin is able to bind polymerized tubulin 
(Kirsch et al. 1991). Gephyrin can interact with the large intracellular loop of GlyRb via a high-
affinity binding site. The identified α subunits of the GlyR as well as many GABAA receptors cannot 
form connections with gephyrin (Kirsch et al. 1995). Gephyrin consists of three major domains: the N-
terminal G (20 kDa) and the C-terminal E domain (43 kDa, Figure 5 and Figure 6) got their denomina-
tion because of their sequence analogy with the bacterial Moco-synthesizing enzymes (MogA and 
MoeA). The two mentioned domains are linked by the so-called C (central) domain (18-21 kDa). The 
isolated G domain is able to form stable trimers depending on yet identified residues. In contrast, the 
isolated E domain forms dimers and includes the alluded binding site for the GlyR  subunit (Figure 
6A). The “linker region” or C domain of gephyrin occupies several binding sites for interacting pro-
teins such as dynein light chain 1 and 2 (Dlc 1 and 2) and collybistin. 
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The clustering of the GlyR at postsynaptic sites is dependent on synaptic activity (Kirsch and Betz 
1998). Since GlyR clustering is abolished in gephyrin knockout mice as well as in SN cultures treated 
with antisense-oligonucleotides, that process is obviously mediated by gephyrin (Kirsch et al. 1993, 
Feng et al. 1998). Blocking GlyR activity in cultured spinal neurons by strychnine, results in the loss 
of GlyR as well as gephyrin cluster formation. Instead, the GlyR was observed to reside in large intra-
cellular vesicles probably being endosomes (Kirsch and Betz 1998). Gephyrin is believed to build a 
scaffold submembranously. The linkage of gephyrin trimers and dimers forms this scaffold (Figure 6B 
and C). Onto the described structure, the GlyR molecules are sitting thereby achieving a three-
dimensional shape (Figure 6D). 
Furthermore, it has been shown, that in young cultured spinal neurons (div 5-7) the peak ampli-
tude and frequency of spontaneous glycinergic mIPSCs severely are decreased upon microtubule dis-
ruption via colchicine. After 15-17 days in culture or by the use of GTP as microtubule stabiliser, this 
effect is not occurring any more. Van Zundert et al. propose that in later stages either the microtubules 
are stabilized by e.g. acetylation or MAPs or that the GlyR/gephyrin complexes become independent 
on microtubules (van Zundert et al. 2004). 
Both, GlyR and gephyrin are shown to be co-transported to the plasma membrane, which indicates 
that non-clustered gephyrin binds to the receptor (Hanus et al. 2004). The binding affinity of gephyrin 
to the GlyRb loop can be enhanced by the phosphorylation-dependent binding of Pin1 (peptidyl-prolyl 
isomerase NIMA interacting protein 1), which directs conformational changes to the C domain. Fur-
thermore, there is evidence for the binding of gephyrin to the GlyR to be important for intracellular 
transport, the lateral motility in the membrane (Ehrensperger et al. 2007, Hanus et al. 2006, Dahan et 
al. 2003) and interaction with the cytoskeleton (Charrier et al. 2006). Dlc 1 and 2 are shown to bind to 
the C domain of gephyrin. They are components of motor proteins which likely contribute to gephyrin 
transport along microtubules (Figure 6E) and hence along neuronal processes. Gephyrin located in the 
cytoplasm, mainly represents gephyrin in transit (Maas et al. 2006). Via biochemical, immunocyto-
chemical and time-lapse studies, Maas could recently demonstrate the co-transport of gephyrin and 
GlyRs. He also shows co-localization of dynein and GlyR-gephyrin transport units forming a triple-
complex together (Maas et al. 2006). Mobile transport units are attached to microtubules whereas a 
small proportion of the mentioned triple-complexes are not bound to microtubules. This transport oc-
curs in a retrograde direction. Since Maas shows GlyR-gephyrin complexes not only to move retro-
gradely but also in an anterograde manner, it would be of great interest to identify the responsible ma-
chinery. Supporting Kirsch’s data in 1998, chronic strychnine application increased the number of 
mobile gephyrin by more than 100% together with a clear shift to retrogradely directed transport. 
Thus, there is functional evidence of GlyR-gephyrin co-transport to be likely sensitive to GlyR block-
ade. In this context, strychnine may trigger the disappearance of GlyRs from synapses (Rasmussen et 
al. 2002). After exocytosis at extrasynaptic sites, GlyRs are mainly inserted into synapses by lateral 
diffusion. Endocytosis of GlyRs also occurs at extrasynaptic localizations. In the extrasynaptic mem-
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brane, GlyRs exhibit fast Brownian diffusion. These movements slow down and become confined, 
when the GlyR reaches a synapse and interacts with synaptic gephyrin clusters (Meier et al. 2001). 
Thereby gephyrin enters and leaves active synapses within minutes. 
Furthermore, the gephyrin-associated protein collybistin is able to translocate gephyrin to the 
membrane (Kins et al. 2000) and is necessary for its synaptic targeting (Papadopoulos et al. 2007). 
Since the SH3 domain of collybistin inhibits its membrane-targeting function (Harvey et al., 2004; 
Kins et al., 2000), the domain has to be deactivated in neurons. Interacting with the gephyrin E domain 
and being specific for inhibitory synapses (Varoqueaux et al. 2004), NL2 has been found to possess 
such a capacity (Poulopoulos et al. 2009). 
 
Figure 6: A-D, model of postsynaptic gephyrin scaffold 
formation. A, gephyrin molecules can form dimers with 
their G domains (gray) and trimers with their E domains 
(light blue) resulting in hexamers and serving as the basic 
element of a gephyrin scaffold. The binding sites for the 
GlyR  subunit are indicated by red bands. The suggested 
resting position of the GlyRs is indicated by the red and 
blue pentamers. B, basic scaffold modules are able to 
form square or octagonal shaped formations. C, Square 
shaped structures can aggregate into higher order struc-
tures. D, three-dimensional structure of postsynaptic 
gephyrin scaffold expanding into the cytoplasm. E, 
scheme of the GlyR-gephyrin-dynein complex for retro-
grade transport. 
 
A-D: Fritschy et al. 2008, E: Maas et al. 2006 
 
1.2.3. The GlyR subunit switch 
In the fetal rat, predominantly α2 homomers are expressed (Becker et al. 1988, Malosio et al. 
1991, Watanabe and Akagi 1995). However, the number of homomeric α2 GlyRs decreases strongly 
between birth and postnatal week three, while expression of α1 and  subunits increases over the same 
period. Thus, in the rat, a developmental switch from α2 homomeric GlyRs to α1 heteromeric GlyRs 
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takes place during the mentioned time period (Figure 7). If actually existent, homomeric α1 or 
α3 GlyRs are probably located extrasynaptically because they fail to bind gephyrin. Because α1 exhib-
its the highest expression level of all α subunits in the adult rat (Becker et al. 1988, Malosio et 
al.1991), it is believed that most glycinergic synapses in the adult rat are mediated by α1 GlyRs. 
Since α2 subunit mRNA and protein expression levels dramatically are reduced in early postnatal 
stages, synapses holding α2 GlyRs are probable to be seldom in adulthood. However, a relevant 
number of glycinergic synapses in the inner plexiform layer of the adult mouse retina displays co-
localization of immunoreactivity for the α2 subunit and gephyrin (Haverkamp et al. 2004). Hence, 
α2 subunits are possibly localized at synapses. Indeed, Veruki recently demonstrated functional evi-
dence for α2-mediated synapses on wide-field amacrine cells in the adult rat retina (Veruki et al. 
2007). Since α2 knockout mice lack obvious neurological and visible defects it seems likely that the 
properties of α2-containing GlyRs are not essential for normal central nervous system function and 
that the required procedures are replaced appropriately. Obviously, activation of the GlyRs themselves 
is not required for the mechanism triggering the developmental switch. 
The developmental alteration from depolarizing to hyperpolarizing is believed to happen at the 
same time as the GlyRa2 subunit is exchanged by the adult α1 and α3 subunits. Nevertheless, no com-
plete GlyRa2 down regulation is shown in retina, auditory brainstem and hippocampus (Piechotta et al. 
2001). The hetero-oligomeric 2α1/3 GlyR is characterized by a single channel conductance of about 
50 pS and low sensitivity to picrotoxin and -carboline whereas homo-oligomeric α2 receptors exhibit 
a larger channel conductivity (85 pS) and slower kinetics. Homomeric α GlyRs are also potentially 
inhibited by picrotoxin. Hetero-oligomeric α2 receptors, in contrast, develop a channel conductivity 
of 48 pS. The open time of native GlyR channels in spinal cord slices decreases from 40 ms (E20) to 
6 ms (P22, Takahashi et al. 1992). This confirms Beckers and van Zunderts data that the α2 subunit is 
replaced by the α1 subunit during development (Becker et al. 1988, van Zundert et al. 2004, Figure 7). 
Hence, synapses of immature spinal neurons probably contain α2 hetero-oligomers. 
A brief glycine application onto an in vitro E15 rat spinal cord causes an excitatory response being 
abolished by strychnine (Vinay and Jean-Xavier 2008). Development therefore is beside the subunit 
switch marked by a decline in [Cl−]i resulting in a shift of ECl toward negative potentials and hence 
from depolarization to hyperpolarization. The reversal potential of IPSPs (EIPSP) shifts from above  
(~ -69 mV) to below (~ -74 mV) the resting membrane potential, which holds about -72 mV during the 
first postnatal week. 
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Figure 7: GlyR subunit composition. 
The red barrels represent the α subunit, the blue barrels represent the  subunit of the GlyR. Shown is the alteration of the 
GlyR composition during maturation.  Adapted from J. Kirsch 
 
1.2.4. Splice variants of the GlyR genes 
Different splice variants are yet identified. One of them is α1ins, a rat α1 splice variant character-
ized by an insertion of eight amino acids within the large intracellular loop (between TM3 and TM4) 
owning a potential phosphorylation site (Malosio et al. 1991b). The rat GlyR α2 subunit exhibits two 
splice variants namely α2A and α2B (Kuhse et al. 1991). α2A and α2B differ from each other by V58 
and T59 substitutions in α2B. An additional form of the α2 subunit is α2* which includes the single 
G167E substitution giving rise to strychnine insensitivity. Alternative splicing of the human 
α3 subunit also creates two variants termed α3K and α3L (Nikolic et al. 1998). α3K misses a 15-amino 
acid section in the large intracellular loop. A zebrafish splice variant of GlyR α4 possesses a 15-amino 
acid insert within the ligand-binding domain (Devignot et al. 2003). All GlyR genes share a similar 
exon-intron organization. Thereby, the coding region is distributed over nine exons. This indicates 
phylogenetic gene duplications. 
 
1.2.5. Disease 
Since α1 GlyRs most likely mediate the main part of the glycinergic transmission in spinal cord, 
brainstem and retina, knockdown or knockout of either subunit may direct intense and similar neuro-
logical effects. Indeed reduced expression of either gene causes a hyperplexia phenotype. Mice and 
humans concerned by such a defect exhibit excessive startle reflexes to unexpected stimuli and often 
additional temporary muscular rigidity, which frequently causes an unprotected fall. The human hy-
perplexia or startle disease is hereditary. Characteristic for this disease is the augmented sensitivity to 
the startle response by emotional exertion, nervousness and exhaustion. The described falls result in 
typical chronic injuries. The symptoms are present from birth on. Because of either disruption of GlyR 
surface expression or of reduced ability to conduct chloride ions, the efficiency of glycinergic trans-
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mission in reflex circuits of the spinal cord and brain stem is affected. Thereby the general level of 
motor neuron excitability is elevated. 
The human GlyR α1 gene, which is responsible for the described disorder, is localized at the distal 
part of chromosome 5q (Ryan et al. 1992). R271L or R271Q substitutions in the human GlyR α1 gene 
give rise to the most common autosomal dominant form of the startle disease (Shiang et al. 1993). 
There are also several autosomal recessive forms of the disease, e.g. deletion of one base pair leading 
to a frame shift and thereby to a stop codon prior to the TM1 domain. In the  subunit, compound 
heterozygous mutations have been identified. The missense mutation G229D and a splice site mutation 
resulting in a cutting-out of exon 5 appear simultaneously. The G229D mutation alone directs a mod-
erate (4-fold) decline of the glycine sensitivity of recombinant α1 GlyRs, whereas the excision of 
exon 5 would probably exclude the expression of functional  subunits. No startle mutations have 
been found until now in the α2 and α3 gene. Likewise, it has not been determined whether up regula-
tion of these subunits compensates α1 subunit expression deficits. The startle disease is medicated by 
clonazepam likely to potentiate the GABAAR. Indeed GABAergic neurotransmission in the spinal 
cord may be up regulated during development in spastic mice and myoclonic cattle to compensate the 
loss of glycinergic transmission (Graham et al. 2003, Lummis et al. 1990). A hereditary mutation in 
the GlyR binding partner gephyrin gene also gives rise to a hyperplexia phenotype in humans (Rees et 
al. 2003). In mice, targeted deletion of the GlyT2 gene leads to this phenotype (Gomeza et al. 2003). 
Mice also are shown to develop startle syndromes. The symptoms of the three naturally occurring 
hyperplexias resemble those of humans. In contrast to humans, the startle symptoms appear not until 
P20, when the developmental subunit switch is supposed to be completed. Thereby, the so-called spas-
tic mouse, that already was identified in the 1960s, (Meier and Chai 1970) is best described. The func-
tion of expressed receptors is normal, but the number of GlyR α1 subunits is diminished in this auto-
somal recessive disorder. Aberrant splicing of the GlyR  subunit gene caused by an insertion within 
intron 5 produces an accumulation of unfinished protein and hence reduced surface expression of 
functional  subunits (Mulhardt et al. 1994). Probably the loss of the  subunit anchoring function 
impairs efficient recruitment of receptors to the membrane or rather postsynaptic sites. Electrophysio-
logical measurements reveal significantly reduced dimensions of glycinergic IPSPs in motor and sen-
sory neurons compared to wild type (Graham et al. 2003). 
In spasmodic mice, the α1 subunit carries the point mutation A52S leading to a modest 6-fold re-
duction in glycine sensitivity (Ryan et al. 1994). 
Homozygous mice suffering from the oscillator variant of the spasmodic form, die of a strong mo-
tor tremor three weeks after birth (Kling et al 1997). Caused by a frameshift mutation in the TM3-
TM4 domain the translation of the α1 subunit rests incomplete. Predicted not to possess the 
α1 heteromers mediating glycinergic transmission at P20, oscillator mice indeed exhibit a 90%-
reduction in strychnine binding in isolated membranes of the spinal cord. This suggests a loss of func-
tional α1 subunit expression (Buckwalter et al. 1994). However, the dimension of strychnine-sensitive 
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synaptic currents was only reduced by 50% in dorsal horn sensory neurons of homozygous mice (Gra-
ham et al. 2003). The examination of this phenomenon and discovering of compensating mechanisms 
would be of great interest. 
 
1.3. Cation-chloride cotransporters (CCCs) 
1.3.1. Isoforms and splice variants 
Beside ion channels, also ion transporters mediate ion trafficking across biological membranes. 
Therefore, ion transporters are as important in generating electrical signals as ion channels. 
In mammals, nine members of the CCC family, encoded by the genes Slc12a 1-9, are currently 
known (Blasse et al. 2009). According to their function, three categories have been determined: two 
members belong to the loop diuretic-sensitive Na-K-2Cl cotransporters (NKCCs) represented by the 
two isoforms NKCC1 and NKCC2. One is a thiazide-sensitive Na-Cl cotransporter (NCC) and four 
isoforms display K-Cl cotransporters (KCC1-4). The remaining CCCs (Slc12a8 and Slc12a9 or CIP 
and CCC9 respectively) are physiologically not sufficient characterized. NKCC1 is expressed in non-
epithelial cells and in basolateral membrane of epithelial cells whereas NKCC2 as apical form only is 
expressed in the thick ascending limb of the Henle’s loop in kidney. The other apical isoform NCC is 
exclusively present in the distal convoluted tubule of the kidney (Figure 8A). KCC1 seems to work as 
a “household” isoform in glial and other cell types but not in neurons. KCC2, in contrast, is exclu-
sively present in CNS neurons (Blaesse et al. 2009). KCC3 is expressed in diverse brain regions, mus-
cle, lung, heart and also kidney and exhibits a developmental increase in protein expression similar to 
that of KCC2. KCC4 is strongly expressed in muscle, pancreas and the embryonic brain (Figure 8A) 
but its role in the nervous system still is unknown.  
The CCCs possess a relative small intracellular N-terminus, adjacent 12 α-helical transmembrane 
domains and a large intracellular C-terminus (about half of the protein, Figure 8B). From TM5 to 
TM6, a large extracellular loop comprising a couple of consensus N-linked glycosylation sites ranges 
in KCCs and CCC8. The same appears between TM7 and TM8 in NKCC1, NKCC2 and NCC. All 
members are glycoproteins with molecular weights in the range of 120-200 kDa (Payne et al. 2003). 
Relating to alternative splicing, variants are known for KCC1, KCC2, KCC3, NKCC1 and 
NKCC2. KCC3a is exclusively expressed in glial cells, KCC3b is found in organs outside the CNS 
and KCC3c is restricted to neurons. The NKCC1 gene offers two variants: NKCC1a and NKCC1b 
both being expressed ubiquitously. NKCC2 even offers six alternative isoforms differing in function. 
Of KCC2 (Slc12a5), two isoforms named KCC2a and KCC2b, differing in promoters and first exons, 
are currently known. Interestingly, the mRNA expression of both isoforms is similar in the neonatal 
mouse but postnatally, the overall expression of KCC2a remains constant and that of KCC2b is exces-
sively up regulated. This suggests KCC2b to be responsible for the yet mentioned developmental shift 
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of the intracellular chloride level. Indeed GABAergic responses remain depolarizing in cortical cul-
tures from KCC2b knockout mice (Zhu et al. 2005). These mice are viable but exhibit abnormal pos-
ture and movement as well as numerous seizures within a few postnatal days. They die about 2 weeks 
after birth. Mice missing KCC2 expression completely die instantly after birth of respiratory failure 
(Hübner et al. 2001). 
In tissue, CCC homo-oligomers have been detected whereas exogenously expressed CCCs are also 
able to form hetero-oligomers. 
 
Figure 8: Phylogenetic tree of human cation–chloride cotransporters (CCCs) and structure of the K+–Cl- cotransporter 2 
(KCC2). A, The percentage of identical residues between aligned protein sequences is shown at branch points. Human pro-
tein sequences were aligned and the phylogenetic tree constructed using CLUSTALW. The predominant tissue expression is 
listed for each CCC and those identified in nervous tissue are indicated by asterisks. B, Model of the KCC2 protein and simi-
larity to KCC1. Putative transmembrane segments were predicted based on hydropathy analysis using the Kyte–Doolittle 
algorithm. Secondary structural elements were predicted using the PHD server (helices represent α structures; wavy lines 
represent  structures). Rat KCC2 and rabbit KCC1 are compared with one another: red residues are identical between KCC2 
and KCC1; black residues are absent from KCC1. Potential asparagine-linked glycosylation sites between putative trans-
membrane segments 5 and 6 are indicated with branched lines. Payne et al. 2003 
 
1.3.2. Function and regulation 
The potassium-chloride co-transport is the electroneutral-coupled movement of K+ and Cl- ions 
without changing the net charge across the membrane. All potassium-chloride cotransporters are sec-
ondary active transporters getting the energy for the transport of the driven ion from the electrochemi-
cal gradient of another ion species. This gradient is established by the work of the Na+/K+-ATPase. In 
addition, other secondary active transporters like Na+-dependent and Na+-independent anion exchang-
ers (NDAE and AE respectively) can take part in the neuronal Cl- homeostasis by exchanging Cl- for 
HCO3-. As being electroneutral, they can work bi-directional and thus are able to conduct net ion in-
flux or efflux depending on the concentration gradients of the transported ions (Gamba et al. 1994). 
In most neurons, chloride accumulation within the cell is mediated by NKCC1 utilizing plas-
malemmal Na+ gradients as energy source for Na-K-2Cl co-transport. Expulsion of chloride in contrast 
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is offered by the K+-gradient. In nervous tissue, KCC2 and NKCC1 seem to be the essential players in 
maintaining Cl- balance. 
NKCC1 and KCC2 are regulated by different kinases modulating their activity. Nevertheless, their 
role for regulating the intracellular chloride level seems to be dependent on gene expression. 
The ubiquitously present potassium-chloride co-transport regulates cell homeostasis namely con-
stancy of cell volume and chemical composition of intracellular compartments. Many studies demon-
strated that K-Cl co-transport is among others activated by cell swelling and in turn regulates the cell 
volume (regulatory volume decrease or RVD, Adragna et al. 2004) in non-neuronal cells. Cell swell-
ing in non-neuronal cells is evoked by hypotonia and thus water influx whereas in neurons intense 
synaptic activity and thereby channel-mediated cation- and chloride-influx induce water inflow. The 
recovery in neurons can be mediated by a volume sensor, being able to activate the K-Cl co-transport 
or/and an augmented driving force for the transport caused by an increased Cl--level inside the cell. 
KCC3 knockout mice show impaired cell volume recovery in cortical neurons after hypotonic swell-
ing suggesting a role of KCC3 in neuronal volume regulation (Boettger et al. 2003). 
Recently, it was shown that the K-Cl cotransporter is critical for controlling the electrochemical 
Cl--gradient being required for the hyperpolarization mediated by GABAARs and GlyRs (Figure 9). 
The depolarization evoked by GABA in early development induces Ca2+-influx via NMDARs as well 
as voltage-dependent Ca2+-channels (Figure 9). The latter leads to significant neurodevelopmental 
consequences in proliferation and migration of neurons and neural precursors (Mercado et al. 2004). 
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Figure 9: Ion-Transport mechanisms underlying GABAAR- (and not shown GlyR) mediated responses in immature and 
mature neurons. Left: early in development NKCC1 mediates Cl--uptake in immature hippocampal and cortical neurons 
maintaining high [Cl-]i. Binding of GABA to its receptor directs Cl--efflux and induces excitation which in turn removes the 
Mg2+-block from the NMDAR and permits Ca2+-influx through voltage-gated Ca2+-channels (VDCCs) and NMDARs (in 
presence of glutamate). Right: in mature CNS neurons, KCC2 is the principal K-Cl cotransporter producing low chloride 
levels within the cell. Upon GABAAR activation, inhibition occurs, VDCCs are failed to be opened and Mg2+ is not removed 
from NMDARs. Following epileptic activity, axotomy or neuronal trauma, the Cl- homeostasis is reversed resulting in excita-
tory responses to GABA (arrow to the left). Middle: in response to more physiological levels of activity (e.g. postsynaptic 
spiking and rebound burst activity), or in the presence of neurotrophic factors, a decrease in the Cl--extruding capacity of 
KCC2 leads to a positive shift in EGABA. Depending on the extent of Cl- accumulation in the neuron, GABAergic neurotrans-
mission might activate VDCCs and remove the Mg2+ block from the NMDAR. The positive shift in EGABA might result in a 
depolarizing postsynaptic current that does not reach the threshold for generating an action potential and still exerts an inhibi-
tory effect by shunting excitatory current. Fiumelli and Woodin 2007 
 
1.3.3. Pharmacology 
The site responsible for Na+ transport is also able to accept Li+ whereas the K+ accepting site also 
takes Rb+, NH4+ or Cs+ but with different affinities. In terms of anions, only Br- can be transported in 
part by NKCC1 and KCC instead of Cl-. The ‘loop’ diuretic furosemide has an equal potency to inhibit 
both NKCC1 and KCC. Another member of the mentioned diuretics, bumetanide, has a 500fold 
greater affinity for NKCC1 and therefore is able to inhibit NKCC1 significantly in low concentrations 
without concerning KCC. 
17 
Introduction 
1.3.4. The potassium-chloride cotransporter KCC2 
As an electroneutral ion transporter located in the membrane, KCC2 expels chloride from the cell 
by utilizing the outwardly directed driving force of K+ and thus is not dependent on the membrane 
potential. Thereby, KCC2 maintains the intracellular Cl--level lower than predicted by the electro-
chemical equilibrium. The transport is therefore determined by the sum of the chemical potential dif-
ferences of K+ and Cl- (Vinay and Jean-Xavier 2008). Since the intracellular chloride level is low in 
many neurons (7-9 mM), the driving-force for the K-Cl transport is nearby the thermodynamic equi-
librium. Therefore, KCC2 possesses the sensitivity to recognize minimal changes in [Cl-]i or [K+]o. In 
a neuron with relative low intracellular chloride, a 5 mM increase in [K+]o is sufficient to reverse the 
driving-force. 
 
1.3.4.1. KCC2 expression and localization 
KCC2 expression is closely restricted to central neurons. Its mRNA expression is opulent in most 
neurons of the mature CNS but marginally in non-neuronal cells or neuronal precursor cells. KCC2 is 
found in cerebellar granule cells, thalamic relay cells, auditory brainstem neurons and cortical neurons 
(Blaesse et al. 2009). According to the preferred localization of glutamatergic synapses to spines and 
GABAergic ones to dendritic shafts and somata, it might be inspiring that also high levels of KCC2 
are shown to be present in dendritic spines of rat cortical pyramidal neurons and interneurons (Gulyas 
et al. 2001). However Li et al. recently demonstrated a morphogenic role for KCC2 in spine formation 
(Li et al. 2007). In immature neurons of the auditory brainstem and of primary cortical cultures, func-
tionally inactive KCC2 has been found. 
In altricial species such as rats, KCC2 expression at birth is delayed in hippocampus and neocortex 
compared to species with precocious neonates. Within a single species, high expression levels of 
KCC2 are first seen in the spinal cord and subcortical brain regions (Blaesse et al. 2006). In the ventral 
rostral spinal cord of rodents, KCC2 mRNA already is expressed at E12.5 (Hübner et al. 2001, Li et al. 
2002). Its protein level rises until P3-7. 
 
1.3.4.2. KCC2 function and interaction partners 
Early in development, NKCC1 activity leads to accumulation and maintenance of intracellular Cl- 
resulting in depolarizing and hence excitatory GABAergic transmission. During the first neonatal 
weeks, KCC2 is up regulated and starts Cl- extrusion. This process is accompanied by a negative shift 
of the reversal potential for chloride beyond the resting membrane potential. Thus, GABAergic trans-
mission switches from excitatory to inhibitory (Fiumelli and Woodin, 2007). Subsequently, KCC2 is 
responsible for maintaining the low Cl- concentration in mature neurons (Rivera et al. 1999, Hubner et 
al. 2001). 
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The number of GABAergic synapses and the frequency of GABAergic mIPSCs were elevated in 
early hippocampal cultures upon KCC2 overexpression (Chudotvorova et al. 2005). Fitting to that, the 
mIPSC frequency in mice with reduced KCC2 levels is lower. As already mentioned, Li et al. show 
that KCC2 owns a morphogenic role in cortical spine formation during development. Neurons 
achieved from KCC2-/- mice exhibit high motile and branched long dendritic protrusions (5 µm) repre-
senting morphological aberrant “filopodia-like” spines (Li et al. 2007). Transfecting these neurons 
with an N-terminal deletion construct, not being able to mediate transport, could rescue that pheno-
type. Therefore, the role of KCC2 in spine maturation might be based on cytoskeletal interactions and 
not on its transport activity. Via immunoprecipitation assays, the cytoskeletal 4.1N protein was shown 
to interact with the KCC2 C-terminal domain (Li et al. 2007). 4.1N is highly expressed in the postsy-
naptic density and is thought to own an anchoring and targeting function for glutamate receptor sub-
units. 
Ca2+-dependent down regulation of KCC2 activity can be achieved within minutes via postsynap-
tic spiking (10 Hz for 5 min). Consistent with that is an alteration in membrane trafficking and/or post-
translational modifications of KCC2 and not in gene transcription or protein synthesis, which would 
last longer. 
Uvarov et al. demonstrated that the KCC2 gene possesses ten putative transcription factor binding 
sites within its core promoter. EGR4 is shown to bind to one of these sites and it furthermore induces 
KCC2 transcription in neurons (Uvarov et al. 2006). 
Besides its function in both, regulating neuronal activity and activity-dependent synaptic plastic-
ity, such as inducing and maintaining hippocampal long-term potentiation, BDNF also is thought to 
regulate GABAergic transmission and plasticity via coordinating KCC2 expression. During develop-
ment, overexpression of BDNF induces augmented KCC2 expression in the prenatal hippocampus, 
giving rise to an increase of the onset of spontaneous correlated network activity. Mice lacking the 
BDNF receptor TrKB, in contrast, exhibit diminished KCC2 expression and lower intrinsic activity in 
pyramidal neurons as neonates (Fiumelli and Woodin 2007). P8-19 TrKB knockout mice also show 
reduced KCC2 mRNA levels compared to wild-type littermates. Nevertheless, the mRNA levels are 
high enough to maintain the switch from excitation to inhibition. Therefore, BDNF is believed to con-
tribute to the developmental up regulation of KCC2. Premature KCC2 expression in neurons alters 
GABA transmission from excitation to inhibition thereby preventing GABA-induced increase in 
[Ca2+]i (Fiumelli and Woodin 2007). 
In adult networks, KCC2 expression is reduced upon neuronal damage and hyperexcitation. 
Thereby transcription and synthesis of KCC2 is decreased via a BDNF-TrKB pathway. Acute applica-
tion of BDNF to HCN cultures even directs a depolarization of EGABA together with a fast down regu-
lation of KCC2 activity. This might be possible due to a quick turnover of the KCC2 pool provided in 
the membrane. 
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CIP1 has been demonstrated to interact with NKCC1 and to inhibit its transport activity (Caron et 
al. 2000). Regarding the amino acid sequence, CIP1 shares 25% identity with both NKCC1 and KCC2 
but in terms of topology it is closer to KCC2 (Caron et al. 2000). Therefore, it is predicted to interact 
with KCC2 as well. Indeed, CIP1 itself is transport-inactive (Wenz et al. 2009) but expressed together 
with KCC2 in HEK cells, the transport activity of KCC2 is enhanced significantly (Wenz et al. 2009). 
The effect is believed to be achieved by formation of KCC2/CIP hetero-oligomers. Thus, CIP1 has a 
reciprocal effect on KCC2 and NKCC1 respectively. So does the protein phosphatase PP1, which acti-
vates KCCs and deactivates NKCC1 (Adragna et al. 2004). In contrast, the kinases WNK3 or SPAK 
together with WNK4 activate NKCC1 but inactivate KCC2 activity in Xenopus laevis oocytes 
(Gagnon et al. 2006). 
 
1.3.4.3. Disease 
In accordance to the increase in KCC2 expression during development, nociceptive withdrawal re-
flexes are low right after birth and grow with age (Price at al. 2005). 
No or few KCC2 protein leads to a depolarizing (excitatory) action of GABA and glycine in the 
mammalian spinal cord. Beside early development, the same can be observed in a number of patho-
logical conditions, such as epilepsy, neuronal injury and chronic pain. In cortical neurons missing 
KCC2 expression, no developmental reduction of intracellular chloride occurs (Zhu et al., 2005). 
KCC2 knockout mice are signed by serious motor defects and are unable to breathe resulting in suffo-
cation shortly after birth. ‘Hypomorphic’ KCC2 gene-targeted mice, containing 20-30% of normal 
KCC2 levels, are viable and exhibit no obvious behaviour abnormalities. Mice with only 5–10% of 
KCC2 in contrast show spontaneous, generalized seizures and die shortly after birth. 
Jean-Xavier et al. investigated effects of spinal cord injury by transection and concomitant re-
moval of all descending inputs to the lumbar enlargement. EIPSP in lumbar motoneurons at P4-7 was 
significantly higher depolarized (above resting potential) in cord-transected than in control animals 
(below resting potential, Jean-Xavier et al. 2006) and therefore was similar to P0-2control animals. 
The increase in KCC2 immunoreactivity in lumbar motoneurons occurring during the first postnatal 
week in control animals was absent due to spinal cord transection. Motoneurons recorded from treated 
animals were less sensitive to different manipulations as [K+]o-modifications or application of bumet-
anide to block CCCs. These results indicate that pathways, descending from brainstem, play a funda-
mental role in the maturation of inhibitory synaptic transmission by augmenting KCC2 expression in 
development. 
GABA- and glycinergic transmission can rapidly switch from inhibition to excitation in a couple 
of regions of the CNS caused by pathological conditions. Upon epileptiform activity, neuronal damage 
and peripheral nerve-induced chronic pain, KCC2 expression in adult rat neurons is reduced (Vinay 
and Jean-Xavier 2008). This and the concomitant [Cl−]i increases may represent an first response to 
neuronal trauma (Figure 10). Recapitulating early developmental stages, GABA and glycine evoke a 
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depolarization of injured neurons. Hence, Ca2+-channels are activated and Mg2+-blocks are removed 
from NMDARs (Figure 9). These procedures may direct Ca2+-dependent excitotoxicity. Upon adult 
spinal cord injury (SCI), BDNF, being able to down regulate KCC2 expression via TrKB receptor, is 
up regulated within a short time window of 6-24 hrs after SCI. This might rapidly diminish KCC2 
expression. The long term down regulation of KCC2 destabilizes synaptic contacts to motoneurons 
analogue to the decrease of inhibitory reflex mechanisms after SCI. Interestingly, BDNF is down regu-
lated in the lumbar cord seven and fifteen days after SCI compared to control animals. 
 
Figure 10: Hypothetical relationship between cation-chloride cotransporters and spinal cord injury. CCCs are responsible for 
the regulation of [Cl−]i. In immature neurons, [Cl−]i is high and the equilibrium potential of chloride (ECl) is above the resting 
membrane potential (Vm). Activation of GABAARs and GlyRs may even trigger cell firing, when ECl is above action poten-
tial threshold (VT). Consequently, “inhibitory” interneurons, within the spinal locomotor network, may have a physiological 
role similar to that of excitatory interneurons. NKCC1 is responsible for intracellular Cl− accumulation. [Cl−]i decreases with 
age upon up-regulation of KCC2; ECl shifts to values below Vm. As a result, the strength of inhibitory connections increases.Vin
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 2. Aim of study 
The aim of this study was to get deeper insights in the still unknown process of the developmental 
switch occurring in spinal neurons. During this process, the GlyR assembly is altered and the juvenile 
GlyRa2 subunit recedes for the benefit of the adult GlyRa1 subunit. Therefore, expression profiles of 
the distinct subunits should be performed in vitro. To address the question whether the activity of the 
GlyR contributes to the switch, strychnine treatments are intended. Since KCC2 plays a major role in 
reversing the chloride level within the neurons during the critical time window and therefore being 
crucial for the switch, its expression profile also has to be determined. The role of KCC2 is further 
investigated utilizing RNAi technology. 
The expression profiles for the GlyR subunits and KCC2 of embryonic rat spinal neurons were ob-
tained via RT-PCR as well as RTq-PCR. The latter allows a semi-quantitative determination of mRNA 
expression in the cells. Furthermore, protein levels were determined if possible. The experimental 
approach was to culture the cells for a certain number of days, take protein and RNA extracts followed 
by immunoblot or RT-PCR analysis. By means of these studies, an approximate time window of the 
subunit switch to occur could be established. 
Towards the observation that GlyR blockade might negatively regulate KCC2 protein expression, 
distinct treatments were carried out to specialize the effects. SN cultures were treated with given con-
centrations of Ca2+ channel inhibitors, Ca2+ chelators and other receptor blockers, protein extracts were 
prepared and the results were obtained by immunoblot analysis. These experiments should shed light 
on the question whether Ca2+-influx or presence is involved in regulating KCC2 expression. 
To address the upcoming question whether KCC2 contributes to the developmental switch of the 
GlyR subunits, shRNA oligos silencing KCC2 expression were designed, cloned into lentiviral vectors 
and transduced to the neurons. Uninfected cells or cells transduced by mismatch shRNA oligos with-
out the ability to induce KCC2 knockdown acted as controls. The neurons were cultured, infected by 
the lentivirus and incubated for 4-32 days. Then cells were either lysed, protein extracts were taken 
and immunoblots were prepared, or cells were fixed and immunohistochemistry against different syn-
aptic proteins was performed. Therewith, effects of KCC2 knockdown onto the different GlyR sub-
units, gephyrin and some other synaptic proteins should be clarified. 
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 3. Material and Methods 
3.1. Material 
3.1.1. Chemicals 
AppliChem DTT 
 EDTA 
 Glycerol 
 Glycine 
 Na2HPO4* 2 H2O 
 NaH2PO4* H2O 
BD Bacto Trypton 
BioRad Acrylamide/Bisacrylamide 30 % (w/v) 
Braun Aqua ad injectabilia 
Finnzymes Phusion® High-Fidelity DNA Polymerase 
 5x Phusion HF Buffer 
Fluka NP-40 
Grüssing Di-Sodiumtetraborate* 10 H2O 
Invitrogen Kanamycine 
 Select Agar 
 Agarose (electrophoresis grade) 
 DMEM 
 D-PBS 
 FCS 
 HBSS 
 L-Glutamine, 100x 
 Neurobasal 
 Optimem 
 Pen/Strep, 100x 
 Horse serum 
 Trypsin 
 Trypsin/EDTA 
 Cell culture water 
 Zeocin, 2000x 
J.T. Baker Boric acid 
Merck Ethanol 
 Isopropanol 
 Methanol 
 Triton X-100 
PAA Laboratories BSA 
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PAN Biotech GMBH Neuropan 27 Supplement, 50x 
Riedel de Haën PFA 
Roche Biochemicals Protease-Inhibitors, tablets EDTA-free 
Roth Ampicillin 
 APS 
 Beta-Mercaptoethanol 
 DABCO  
 Ethidiumbromide 
 Yeast extract 
 Milk powder 
 Mowiol 4.88 
 TRIS 
 Tween-20 
Serva SDS 
Sigma-Aldrich Bromphenol Blau 
 DOC 
 Poly-DL-Ornithine 
 Poly-L-Lysine 
 TEMED 
 Trypan Blue 
 PEI 
VWR Sodiumchloride 
 
3.1.2. Equipment 
AGFA Gewaert Developing Machine Curix 60 
Amersham Bioscience Spectrophotometer UltroSpec 3100 pro UV/Visible  
Applied Biosystems ABI Prism sequence detection system 
Astacus Water Preparation Membra Pure 
Beckman Coulter Ultracentrifuge (Optima LE-80K) 
 Ultracentrifuge rotor SW32Ti 
 Avanti J-25 Centrifuge 
Bender und Hobein AG Vortex Genie 2 G-560E 
BioRad Trans-Blot SD cell 
 GS-800 Calibrated Densitometer 
 PCR Machine 
 Power Supply PowerPac 200 
 Mini protean III Gel System 
CAT Rocker ST5 
Eppendorf Heating block 
GFL Water Bath Type 1008 
Heidolph Magnet stir MR 2002 
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Heraeus Instruments Shaking Incubator 
 Oven 
Herolab Gel Documentation System 
Hettich Micro 200R table-top centrifuge 
 Table centrifuge 
Hirschmann Pipet aid 
 Glass Pipet (1 ml, 2 ml, 5 ml, 10 ml) 
Holten Sterile Workflow LaminAir Model 1.2 
IBS Integra Bioscience Autoclave 
Kendro Laboratory Products GmbH Sterile Workflow HERA safe 
Kern und Sohn GmbH  Analytical Balance 440-33N 
Leica S6E Binocular 
 KL 1500 LCD light source 
Marienfeld Neubauer counting chamber 
Mettler Toledo pH Meter 
MS Laborgeräte Incubator 
Nuaire CO2 Incubator, water-jacketed 
Supplier Equipment 
Visitron Systems CCD Camera (SpotRT) 
Zeiss Objective Plan NeoFLUAR 40x/1.3 Oil 
 Objective Plan Apochromat 63x/1.4 Oil 
 Objective Plan FLUAR 100x/1.45 Oil 
 Microscope Axiovert 200M 
 Light Source FluoArc 
 
3.1.3. Software 
Adobe Photoshop 
 InDesign 
 Acrobat 
Applied Biosystems ABI Prism 7000 
Bio-Rad Laboratories GeneX 
 QuantityOne 
Microsoft Excel 
 Word 
 PowerPoint 
Visitron Systems Metamorph Software (Version 6.2r6) 
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3.1.4. Disposables 
BD Falcon Cell Strainer 100 µm 
BD Microlance Injection Needles (20 G, 21 G, 24 G) 
BD Plastipak Syringes (1 ml) 
Beranek Ultracentrifugation tubes (25 x 89 mm) 
Corning Incorporated Cell scraper 
Falcon Cell culture dishes (3,5 cm, 6-well, 24-well) 
 Reaction tubes (15 ml, 50 ml) 
GE Healthcare Amersham Hyperfilm ECL 
Greiner bio-one Reaction tubes (0,5 ml, 1,5 ml, 2 ml) 
 Petri dishes 
 Pipet tips (10 μl, 20 μl, 200 μl, 1 ml) 
 PET tubes (14 ml) 
Hartmann Gloves S, Peha-soft 
Kisker Quali-PCR-Plates 
Marienfeld Glass slides 
 Cover slips (12 mm, 13 mm) 
Millipore Sterile filter 0,22 µm, 150 ml (Steritop-GP) 45 mm width 
 PVDF-Membrane 
 Syringe filter 0,45 μm 
Nerbe plus adhesive cover for RTq-PCR Plates  
Pechiney Parafilm 
Sarstedt Plastic cuvettes 1 ml 
 Serological Pipets (5 ml, 10 ml, 25 ml) 
Schleicher und Schuell Whatman 
Starlab Pipet tips (10 μl, 20 μl, 200 μl, 1 ml) 
VWR Gloves S, Nitril 
Zeiss Immersol Immersionoil 
 
3.1.5. Kits 
Applied Biosystems TaqMan Master Mix 
 TaqMan Gene Expr. Assay Rn00592624_m1, inventoried (KCC2) 
 TaqMan Gene Expr. Assay Rn00595017_m1, inventoried (Enolase) 
 TaqMan Gene Expr. Assay Rn00565582_m1, inventoried (GlyRa1) 
 TaqMan Gene Expr. Assay Rn01420724_m1, inventoried (GlyRa2) 
 TaqMan Gene Expr. Assay Rn01638847_m1, inventoried (GlyRa3) 
 TaqMan Gene Expr. Assay Rn00583966_m1, inventoried (GlyRb) 
 TaqMan Gene Expr. Assay Rn99999916_s1, inventoried (GAPDH) 
 TaqMan Gene Expr. Assay Rn00575867_m1, inventoried (gephyrin) 
GE Healthcare Amersham™ ECL™ Plus 
Invitrogen SuperScript® III First-Strand Synthesis System 
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Macherey-Nagel NucleoBond® Xtra Midi/Maxi-Kit 
 NucleoSpin® RNA II 
Qiagen QIAquick Gel Extraction Kit 
Roche Applied Science Rapid DNA Ligation Kit 
Stratagene QuikChange Site-Directed Mutagenesis Kit 
Thermo Scientific BCA Protein Assay 
 
3.1.6. Buffers, Solutions, Culture Media 
3.1.6.1. Cell Culture 
Boric acid 150 mM H3BO3 in Milli-Q, pH8.3 
DMEM+++ 10 % (v/v) FCS, 1 % (v/v) P/S, 0,5 % (v/v) Glutamine in NB 
D-PBS/Glucose 5 % 20x Glucose in D-PBS 
Glucose, 20x 12 % (w/v) Glucose (for cell culture) in cell culture water 
MEF medium 10 % (v/v) FCS, 1 % (v/v) P/S in DMEM 
NB+++ 0,25 % (v/v) Glutamine, 1 % (v/v) P/S, 2 % (v/v) Neuropan 27 in NB 
NB++++ 1 % (v/v) Glutamine, 0,1 % (v/v) P/S, 2 % (v/v) Neuropan 27, 0.2 % (v/v) 
Holo-Transferrin in NB 
o/n medium 10 % (v/v) FCS, 1 % (v/v) P/S in NB 
Poly-Ornithine, 5x 500 mg/l in H3BO3 
 
3.1.6.2. Molecular Biology 
Annealing buffer 100mM Kaliumacetate, 30 mM HEPES (pH7.4), 2 mM Magnesium-
acetate in autoclaved Milli-Q 
DNA loading buffer, 10x 30 % (v/v) Glycerol, 0.1 % (w/v) OrangeG in autoclaved Milli-Q 
Innou transformation buffer 55 mM MnCl2* 4 H2O, 15 mM CaCl2* 2 H2O, 250 mM KCl, 10 mM 
PIPES in Milli-Q 
LB agar 1.5 % (w/v) Select-Agar in LB-Medium 
LB medium 1 % (w/v) NaCl, 1 % (w/v) Bacto-Trypton, 0.5 % (w/v) yeast extract 
in Milli-Q 
Lysis buffer P2 200 mM NaOH, 1 % (w/v) SDS in autoclaved Milli-Q 
Neutralisation buffer P3 3 M KOAc, pH5.5 in Milli-Q 
PIPES 0.5 M PIPES, pH6.7 
Resuspension buffer P1 50 mM Tris-HCl pH8, 10 mM EDTA,10 % (w/v) RNase A 
SOB-Medium 0.05 % (w/v) NaCl, 2 % (w/v) Bacto-Trypton, 0.5 % (w/v) yeast 
extract, 2.5 mM KCl (pH7) in Milli-Q; add 10 mM MgCl2 before use 
TAE, 50x 242 g/l Tris base, 37.2 g/l Na2EDTA* 2 H2O, 5.71 % (v/v) Acetic 
acid in Milli-Q 
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3.1.6.3. Immunohistochemistry 
Blocking solution A 1 % (w/v) BSA, 5 % (v/v) Horse Serum, 0.5 % (v/v) Triton X-100 in 
1xPBS 
Blocking solution B 1 % (w/v) BSA, 5 % (v/v) Horse Serum in 1xPBS 
PBS, 10x 137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4* 2 H2O, 1.4 mM KH2PO4 in 
Milli-Q, pH7.3 
 
3.1.6.4. Biochemistry 
Blocking buffer 5 % milk powder in TBS-T 
Complete Solution 1 tablet in 2 ml of autoclaved Milli-Q 
RIPA 50 mM Tris-HCl, 1 % (v/v) Triton X-100, 1 % (w/v) SDS, 150 
mM NaCl, 1 mM EDTA, 1% (w/v) DOC, 4 % (v/v) Complete 
Solution in autoclaved Milli-Q 
SDS running buffer, 10x 3.029 % (w/v) Tris-base, 14.413 % (w/v) Glycine, 1 % (w/v) 
SDS in Milli-Q 
TBS, 10x 1.5 M NaCl, 1.18 % (w/v) Tris-base, 6.35 % (w/v) Tris-acid in 
Milli-Q 
TBS-T 0.05 % (v/v) Tween-20 in 1xTBS 
Transfer buffer (semi-dry blot) 25 mM Tris-HCl, 150 mM Glycine, 10 % (v/v) MeOH in Milli-
Q 
Transfer Buffer (tankblot) 0.381 % (w/v) Na2B4O7*10 H2O in Milli-Q 
Urea sample buffer, 2x 8 M Urea, 20 mM DTT, 125 mM Tris-HCl, 5 % (w/v) SDS, 
0.01 % (w/v) Bromphenolblue, 20 % (v/v) Glycerol in Milli-Q 
 
3.1.7. Antibodies 
3.1.7.1. Primary Antibodies 
Antigen/Antibody Species Dilution IF/IB [kDa] Source 
-tubulin ms -/1:25.000 50 Sigma-Aldrich 
408 (gephyrin AA 175-191) rb 1:500/1:200 93 Nawrotzki (unpubl.) 
GABAAR bd17, -chain ms 1:100/1:500 55 Chemicon, Fritschy et al. 1992 
GABAAγ2 gpig 1:100/1:25 43 Fritschy and Mohler 1995 
mAb2 (GlyRa1) ms 1:100/1:100 48 Pfeiffer et al. 1984 
mAb4 (all GlyRa subunits) ms 1:100/1:100 48 Pfeiffer et al. 1984 
mAb7 (gephyrin) ms 1:200/1:500 93 Pfeiffer et al. 1984 
Neuron specific enolase γ2 ms 1:10/1:2000 47 Chemicon 
NMDAR1 ms -/1:5000 106 Millipore 
Phospho-eEF2 (Thr56) rb -/1:1000 95 CellSignaling 
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Antigen/Antibody Species Dilution IF/IB [kDa] Source 
Phospho-S6 Ribosomal  
Protein 
rb 1:50/1:5000 32 CellSignaling 
VIAAT ms 1:500/- - Sigma-Aldrich 
αGFP/FITC gt 1:1000/- 27 USBiological  
αGlyRC-20 gt -/1:100 58 Santa Cruz 
αGlyRα2 gt 1:100/1:100 48 Santa Cruz 
αGlyRα rb -/1:1000 48 Millipore 
αKCC2-1 (N-Terminal) rb 1:1000/1:5000 124 Kind gift of Prof. Friauf 
αPSD 95 ms 1:250/1:5000 95 Transduction Laboratories 
 
3.1.7.2. Secondary Antibodies 
Antibody Conjugation Dilution Source 
dk anti gt IgG cy2 1:200 Dianova 
dk anti gt IgG HRP 1:10,000 BioRad 
dk anti ms IgG cy3 1:1000 Dianova 
dk anti ms IgG HRP 1:10,000 BioRad 
dk anti rb IgG HRP 1:10,000 BioRad 
gt anti rb IgG cy3 1:1000 Dianova 
ms -Actin/ HRP 1:200,000 Sigma-Aldrich 
 
3.1.8. Plasmids and Sequences 
3.1.8.1. ShRNA 
The shRNA Oligos were synthesized either at BioSpring or at Eurofins MWG Operon. 
shRNA Oligos inducing KCC2 knockdown 
KCC2kd1, sense 
(located in the 3’UTR) 
5’-TTTGCCGGAGTAGACGTTGCAATAAGTGAAGCC 
ACAGATGTTATTGCAACGTCTACTCCGGTTTTT-3’ 
KCC2kd1, antisense 5’-CGAAAAACCGGAGTAGACGTTGCAATAACATCT 
GTGGCTTCACTTATTGCAACGTCTACTCCGG-3’ 
KCC2kd2, sense (kd2) 
(located in the ORF) 
5’-TTTGAGAGCGACATCTCAGCATACAGTGAAGCC 
ACAGATGTGTATGCTGAGATGTCGCTCTTTTTT-3’ 
KCC2kd2, antisense 5’-CGAAAAAAGAGCGACATCTCAGCATACACATCT 
GTGGCTTCACTGTATGCTGAGATGTCGCTCT-3’ 
KCC2kd3 sense 
(located in the ORF) 
5’-TTTGAGAGTATGATGGCAGGAACATGTGAAGCC 
ACAGATGATGTTCCTGCCATCATACTCTTTTTT-3’ 
KCC2kd3 antisense 5’-CGAAAAAAGAGTATGATGGCAGGAACATCATCT 
GTGGCTTCACATGTTCCTGCCATCATACTCT-3’ 
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shRNA Oligos inducing KCC2 knockdown 
KCC2kd4, sense 
(located in the ORF) 
5’-TTTGGCTGTCTCGCCATGGCTTTGAGTGAAGCC 
ACAGATGTCAAAGCCATGGCGAGACAGCTTTTT-3’ 
KCC2kd4, antisense 5’-CGAAAAAGCTGTCTCGCCATGGCTTTGACATCT 
GTGGCTTCACTCAAAGCCATGGCGAGACAGC-3’ 
 
Mismatch shRNA Oligo accordant to KCC2kd2 without silencing effect 
KCC2kd2mm, sense 5’-TTTGAGAGCGATATTTCAGCGTACAGTGAAGCC 
ACAGATGTGTACGCTGAAATATCGCTCTTTTTT-3’ 
KCC2kd2mm, antisense 5’-CGAAAAAAGAGCGATATTTCAGCGTACACATCT 
GTGGCTTCACTGTACGCTGAAATATCGCTCT-3’ 
 
3.1.8.2. Vectors, Plasmids 
Plasmid Description Source 
pCMV-U6 Eukaryotic expression vector carrying the 
MCS downstream to the U6-Promoter 
Dittgen et al. 2004 
pCMV-U6_KCC2kd1 shRNA Oligo against KCC2 in pCMV-U6 via 
BbsI/BstBI restriction sites 
this thesis 
pCMV-U6_KCC2kd2 shRNA Oligo against KCC2 in pCMV-U6 via 
BbsI/BstBI restriction sites 
this thesis 
pCMV-U6_KCC2kd3 shRNA Oligo against KCC2 in pCMV-U6 via 
BbsI/BstBI restriction sites 
this thesis 
pCMV-U6_KCC2kd4 shRNA Oligo against KCC2 in pCMV-U6 via 
BbsI/BstBI restriction sites 
this thesis 
pCMV-U6_KCC2kd2mm mmshRNA Oligo against KCC2 in pCMV-U6 
via BbsI/BstBI restriction sites 
this thesis 
pCMV 8.9 Lentiviral packaging vector Zufferey et al. 1997 
pVSVG Lentiviral envelope vector Naldini et al. 1996 
pFSGW Based on pFUGW; the ubiquitin promoter 
was replaced by the human synapsin promoter 
Thomas Kremer 
pFSGW_KCC2kd2 shRNA Oligo against KCC2 under the U6 
promoter in pFSGW via BstBI/NheI restric-
tion sites 
this thesis 
pFSGW_KCC2mm shRNA Oligo against KCC2; contains 3 mis-
matches compared to the KCC2kd2 Oligo, 
under the U6 promoter in pFSGW via 
BstBI/NheI restriction sites 
this thesis 
hGlyRa1 in pcis Eukaryotic expression vector for the human 
GlyRa1 subunit 
Grenningloh et al. 1990 
hGlyRa2 in pcis Eukaryotic expression vector for the human 
GlyRa2 subunit 
Grenningloh et al. 1990 
rGlyRa3 in pcis Eukaryotic expression vector for the rat 
GlyRa3 subunit 
Kuhse et al. 1990 
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Plasmid Description Source 
rGlyRb in pcis Eukaryotic expression vector for the rat 
GlyRb subunit 
Grenningloh et al. 1990 
KCC2_rn in pEFGP-N3 Eukaryotic expression vector for rat KCC2, 
C-terminally tagged to EGFP 
Kai Kaila 
KCC2_rn in pEGFP-C1 Eukaryotic expression vector for rat KCC2, 
N-terminally tagged to EGFP 
Kai Kaila 
KCC2-IRES Eukaryotic expression vector for rat KCC2, 
N-terminally tagged to IRES and EGFP 
Kai Kaila 
 
3.1.8.3. Primer 
The primers for GlyRa2, GlyRa3 und GlyRb subunits originate from Jochen Kuhse. The remaining 
ones were synthesized at BioSpring or GATC. 
Primer Sequence 
GlyRa1-F 5’-TTTTTTGCCCCCATAACTCGTGG-3’ 
GlyRa1-R 5’-TGCTGTAGAGGACATTCCCATTCCG-3’ 
GlyRa2 3UTRs1 5’-CCTGGGACCTTCTTTGCCTAAGTG-3’ 
GlyRa2 3UTR AS1 5’-ATGGTAGTCACTATTGTCAGATGG-3’ 
GlyRa3 3UTRs1 5’-CTATGAAGGCATACAAAAACAGAGC-3’ 
GlyRa3 3UTR AS1 5’-GTGTTCTGACATGAGTGACCTTGAC-3’ 
GlyR s1 5’-TTGGCCTCAGAGTGCACCACCCTC-3’ 
GlyR AS1 5’-CGTGGGGATGACAGGCTTGGCAGG-3’ 
KCC2mut, sense 5’-CTCGTAGGTGTACGCTGATATGTCACTCTCGTGCATC-3’ 
KCC2mut, antisense 5’-GATGCACGAGAGTGACATATCAGCGTACACCTACGAG-3’ 
NheI/5’ U6pro 5’-CCCGCTAGCATCCGACGCCGCCATCTCTA-3’ 
pCMV-U6oligo3’ 5’-CCACCGCATCCCCAGCATGCC-3’ 
 
3.1.9. Antibiotics 
Antibiotic Dilution 
Ampicillin 1:1000 from stock (150 mg/ml) 
Kanamycin 1:1000 from stock (30 mg/ml) 
Zeocin 1:2000 
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3.1.10. Cells 
3.1.10.1. Bacteria 
Stratagene E.coli XL-1 blue 
 
3.1.10.2. Cell lines 
ATCC HEK293, CRL-1537 human embryonic kidney cells 
 HEK293T, CRL-11268 HEK293T cells, stably express the SV-40 T antigen 
 
3.1.11. Inhibitors 
Inhibitor Function concentration solvent 
APV Blocks the NMDAR 30 µM H2O 
bicuculline Blocks the GABAAR and Ca2+-
activated K+-channels 
20 µM H2O 
cnqx Blocks AMPAR and KainateR 2 µM H2O 
gabazine Blocks the GABAAR 10 µM H2O 
mk 801 Blocks the NMDAR (not competi-
tive) 
5 µM H2O 
nifedipine Blocks L-type Ca2+-channels 5-10 µM DMSO 
strychnine Blocks the GlyR 1 µM H2O 
tetrodotoxin Blocks voltage depending Na+-
channels 
1 µM H2O 
verapamil Blocks L-type Ca2+-channels 2 µM H2O 
 
3.1.12. DNA and Protein standards 
Bio-Rad Precision Plus Protein Dual Colour standards 
Invitrogen 100 bp ladder 
 1 kb ladder 
Fermentas Gene Ruler Express 
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3.2. Methods 
3.2.1. Cell culture techniques 
3.2.1.1. Cell lines 
Culture and passaging of HEK293 and HEK293T cells 
Cells are grown in MEF medium on 10 cm cell culture dishes and passaged three times a week as 
follows: cells are rinsed with D-PBS (37°C) and incubated with Trypsin/EDTA for 2 min. They are 
resuspended in fresh medium and centrifuged for 5 min at 500 rpm. The supernatant is removed and 
the cells are resuspended in fresh medium. The cell suspension is diluted 1:5 and 1:10 in fresh medium 
and plated on 10 cm dishes (10 ml) or seeded on poly-L-lysine coated cover slips (500 µl). 
 
PEI-Transfection of cells 
The cells are transfected when they reach 60-70 % density. For one well of a 24-well plate, 1 µg 
DNA is diluted in 50 µl Optimem and 2-3 µl PEI is added quickly followed by 10 s vortexing. After 
30 min of incubation at the dark and RT, the mixture is added to the cell culture medium and distrib-
uted equally. Cells are incubated for 4 h under normal growth conditions, then the medium is replaced 
with fresh MEF medium. The amount of components for the transfection is increased relative to the 
surface of the dish or well. 
 
3.2.1.2. Primary cultures 
Hippocampal neurons (E 19) 
Hippocampi are dissected from Wistar/Crl rats at E 19 and propagated as described previously 
(Dresbach et al. 2003). Briefly, a pregnant rat is anaesthetised and sacrificed. The embryos are taken 
out of the mother and decapitated. The heads are opened and the Hippocampi are removed, treated 
with Trypsin, washed three times with serum containing DMEM and triturated first by a 20 G then by 
a 24 G needle. The cells are counted and plated at a density of 10,000-15,000 cells/cm2 on poly-L-
lysine coated cover slips or 6-well plates in DMEM+++. After 4 h or 1 day, the DMEM is exchanged by 
NB+++. 
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Spinal neurons (E 15) 
Spinal cords are dissected from Wistar/Crl rats at E 15 and propagated as described previously 
(Kirsch and Betz 1995). Briefly, a pregnant rat is anaesthetised and sacrificed. The embryos are re-
moved and after opening of the back, the spinal cords are removed and collected in D-PBS/Glucose. 
After cutting the cords into small pieces, the cells are dissociated by trituration with glass pipettes. The 
single cell suspension is centrifuged, the supernatant is removed and the pellet is solved in NB++++. 
Finally, cells are counted and plated on poly-L-ornithine coated 6-well plates (containing four cover 
slips per well for immunoreactivity or without cover slips for extracts). Per well 400,000 cells are 
filled in. 
 
3.2.2. Molecular biology 
3.2.2.1. Transformation of bacteria (Holger Stuck) 
One Aliquot of competent cells is gently thawed on ice. 50 µl of the cell suspension is mixed with 
0.5 µl of DNA and incubated on ice for 30 min. After a heat shock at 42°C for 30 sec and incubation 
on ice for 1 min, 450 µl of LB medium without antibiotics is added. The mixture is shaken for 45 min 
at 37°C and 180 rpm. At the end 50-100 µl of the cell suspension are streaked on agar dishes contain-
ing the accordant antibiotic. 
 
3.2.2.2. Mini Plasmid Preparation 
A colony is picked with a baked toothpick and thrown into 3 ml of LB medium containing the ac-
cordant antibiotic. The sample is shaken o/n at 37°C. The next day, the cell suspension is centrifuged 
for 5 min at 5000 rpm and 4°C to get the cells pelleted. The pellet is solved in 400 µl P1 containing 
0.4 µl RNaseA. 400 µl P2 are added and the suspension is inverted 2-3 times. After incubation at RT 
for 5 min, another 400 µl ice-cold P3 are added to the mixture. Again, the suspension is inverted and 
incubated for 5 min on ice. Cell debris and denatured proteins are pelleted by centrifugation for 10 min 
at 4°C and 13,000 rpm. The clear supernatant is carefully taken up and filled into a new 2 ml reaction 
tube. The tube is filled to a volume of 2 ml with isopropanol and inverted. The DNA pellet is produced 
by centrifugation for 30 min at RT and full speed. The supernatant is discarded and the DNA pellet is 
washed with 870 µl of 70% EtOH. Finally, the tube is centrifuged again for 10 min at RT and full 
speed, the supernatant is discarded and the pellet is allowed to dry until it becomes transparent. The 
isolated DNA is solved in autoclaved Milli-Q and is prepared for sequencing or stored at -20°C. 
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3.2.2.3. Maxi plasmid preparation 
For the o/d culture, one colony of an agar dish or a glycerol stock is picked with a sterile yellow 
pipet tip and thrown into 5 ml of LB medium without antibiotics. In the evening 2 ml of the cell sus-
pension are added to 500 ml LB medium containing the accordant antibiotic. The mixture is shaken 
o/n at 37°C and 250 rpm. The next day, the DNA is purified using the NucleoBond® Xtra Midi/Maxi-
Kit following the manufacturer’s instructions. The plasmid DNA is eluted in Milli-Q and the OD260/280 
is determined using the photometer. The DNA solution is adjusted to 1 µg/µl and stored at -20°C. 
 
3.2.2.4. Agarose gel electrophoresis 
DNA loading buffer is added to the DNA to a final concentration of 1x. The samples are loaded on 
an agarose gel (0.7-2 % (w/v) in 1x TAE) and the DNA is separated at 80 V for the first 10 min fol-
lowed by 100 V for the rest of the run. Afterwards, the gel is applied to an EtBr bath (in 1x TAE) to 
visualize the DNA and is photographed for documentation. 
 
3.2.2.5. Gel extraction 
For the extraction of DNA out of the agarose gels, the QIAquick Gel Extraction Kit is used. The 
manufacturer’s instructions are followed. 
 
3.2.2.6. Restriction digest  
All used enzymes and buffers originate from NEB. The proposed time durations, temperatures and 
concentration are adopted. For double digests, the optimal conditions are worked out. 
 
3.2.2.7. Mutational assay 
The production of a construct containing mutations at defined sites in the targeted sequence is 
done using the QuikChange Site-Directed Mutagenesis Kit. Primers are designed following the kit’s 
instructions. The PCR was performed as proposed in the manual. 
 
3.2.2.8. Annealing of shRNA 
To anneal the shRNA Oligos, 2 µl of each, sense and antisense solution, are diluted in 46 µl of an-
nealing buffer and heated for 3 min at 90°C in the heating block. Still containing the samples, the 
block is turned off and is allowed to cool down to 37°C. After reaching this temperature, the block is 
turned on again and the RNA is incubated for 1 h at 37°C. The dsRNA is kept at -20°C. 
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3.2.2.9. RNA isolation 
According to the manufacturer’s instructions, total cellular RNA is isolated from 1.2 million cells 
using the Nucleobond RNA II kit. Finally, the RNA is eluted with 30 μl water. To further increase the 
concentration, the eluate was used to elute remaining RNA from the membrane one more time. The 
concentration is determined by UV spectrophotometry at 260 nm. The RNA is stored at -20°C. 
 
3.2.2.10. CDNA synthesis 
The following components of the SuperScript® III First-Strand Synthesis System are mixed in a 
PCR tube. 
 
RNA 8 µl 
OligodT 1 µl 
dNTPs 1 µl 
 
The mixture is incubated at 65°C for 5 min, placed on ice for 1 min and the DNA synthesis mix is 
added. 
 
10x RT Puffer 2 µl 
25 mM MgCl2 4 µl 
0.1 M DTT 2 µl 
RNaseOut 1 µl 
SuperScript III RT 1 µl 
 
This mixture is incubated for 58 min at 50°C and then for 5 min at 85°C. Subsequently it is placed 
on ice and 1 µl of RNaseH is added. Digest of the RNA takes place at 37°C for 20 min. 
 
3.2.2.11. RT-PCR 
The reaction of the RT-PCR takes place in 50 µl volume. Therefore 27 µl of autoclaved Milli-Q 
are mixed with 10 µl 5xPhusion HF Buffer, 5 µl 2.5 mM dNTPs, 1.5 µl DMSO, 2 µl sense and an-
tisense primers respectively, 0.5 µl Phusion Polymerase und 2 µl cDNA. The following conditions are 
applied: 
a) 2 min at 94°C 
b) 50 sec at 94°C 
c) 50 sec at 53°C (GlyRa1), 60°C (GlyRa2, GlyRa3), 68°C (GlyRb) 
d) 50 sec at 72°C 
e) 20 min at 72°C 
Steps b)-d) are repeated 35 times. 
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3.2.2.12. RTq-PCR 
For the PCR samples, a DNA and a reaction mix are prepared. For the DNA mix, 50-100 ng of 
cDNA is solved in autoclaved Milli-Q in a final volume of 13.5 µl. For the reaction mix, 15 µl 
TaqMan Master Mix and 1.5 µl of the accordant Gene Expr. Assay are mixed. The two mixtures are 
combined in the wells of a 96-well plate. Doublets or triplets of each sample are performed. Auto-
claved Milli-Q serves as the negative control. The plate is sealed with an adhesive cover. Before the 
PCR reaction takes place, the plate is centrifuged for 2 min at 1500 rpm to avoid air bubbles within the 
samples. Afterwards, 50 cycles of amplification with the recommended PCR program (a) 2 min 50°C, 
b) 10 min 95°C, c) 15 sec 95°C, d) 1 min 60°C) are performed. For all genes together, the auto-
baseline is adjusted to get rid of noise. For each single gene, the Auto-CT value is adjusted to deter-
mine the point, at which the enzyme-substrate curve switches from linear to the plateau-phase. The 
data are analyzed with the help of the genex.xls macro, which employs the -CT method. 
 
3.2.2.13. Lentivirus 
Production 
The following mixture is prepared to transfect HEK293T cells for virus production: 
plasmid per 10 cm dish 
pCMV R8.9 7.5 µg 
pVSVG 5 µg 
pFSGW + shRNA 10 µg 
PEI 75 µl 
Optimem 925 µl 
 
For an effective approach, four 10 cm dishes of cells are transfected with this mixture respectively. 
After 4 h, the medium is aspirated and replaced by fresh MEF medium (37°C). Two days later, the 
medium is removed, pooled and centrifuged for 5 min at 1291 rpm and RT. The supernatant is sterile 
filtered through a 0.45 µm syringe and transferred to an ultracentrifuge tube (no cap). The virus is 
centrifuged in the following UZ step within a SW32Ti rotor at 25,300 rpm and at 4°C for 90 min. Af-
terwards, the supernatant is carefully aspirated and the viral pellet (yellow-brown) is allowed to dis-
solve in the reflux for 4 h on ice. The reflux volume is measured and filled up with D-PBS to a final 
volume of 500 µl. 15 µl virus aliquots are deep frozen in liquid nitrogen and stored at -80°C. 
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Infection 
One virus aliquot is gently thawed on ice and filled with NB to a volume of 1 ml. 10-80 µl of this 
mixture are dropped to one well of a 6-well plate and well distributed. The cells are incubated at least 
4 days with the virus. Protein extracts or immunoreactivity assays are prepared at div 8, 15, 22 and 36. 
 
3.2.3. Biochemistry 
3.2.3.1. Protein extracts (modified from Santa Cruz) 
The medium is removed and cells are washed once with D-PBS. 1.2 million cells are scraped off 
in 150 μl RIPA buffer and transferred to a 1.5 ml reaction tube. The lysate is passed through a 21 G 
needle 10-15 times to shear genomic DNA. The lysate is cleared by centrifugation at 4°C and full 
speed for 15 min in a tabletop centrifuge. The supernatant is transferred to a new 1.5 ml reaction tube 
and stored at -80°C. 
 
3.2.3.2. BCA-Assay 
The following standards are prepared: 
BSA: 2 mg/ml 
µl µg RIPA µl Milli-Q µl 
0 0 10 40 
0.5 1 10 39.5 
1.25 2.5 10 38.75 
2.5 5 10 37.5 
5 10 10 35 
10 20 10 30 
20 40 10 20 
30 60 10 10 
40 80 10 0 
 
10 µl of the protein extract are mixed with 40 µl of Milli-Q. Doublets or triplets are performed. 
For the BCA reagent, Solution A and B of the BCA Protein Assay are mixed at the ratio of 50:1. 1 ml 
of the BCA reagent is pipetted into each sample. Afterwards the samples are first incubated at 37°C, 
then at RT for 30 min respectively. The protein concentration is measured using the photometer. 
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3.2.3.3. Acrylamide Gels 
The gels for the poly acrylamide gel electrophoresis (PAGE) and adjacent immunoblot analysis 
are mixed as in the following instruction. 
Separation gel, 10% 
2 x 1.5 mm gels 
8 ml H2O 
6.6 ml Acrylamide 
5 ml 1.5 M Tris pH8.8 
200 µl 10% SDS 
200 µl 10% APS 
16 µl TEMED 
 
Stacking gel 
2 x 1.5 mm gels 
5.4 ml H2O 
1340 µl Acrylamide 
1000 µl 1 M Tris pH6.8 
80 µl 10% SDS 
80 µl 10% APS 
16 µl TEMED 
 
The solution is immediately filled between two glass plates. First, the separation gel and, after its 
polymerization, the stacking gel is filled in. 
 
3.2.3.4. PAGE 
The protein extracts are thawed on ice and are drugged with 2x Urea buffer. The samples are 
heated for 5 min at 42°C. 15-40 µg of protein per lane are separated on the acrylamide gel using the 
mini protean III gel system. The separation was performed at 35 mA. The proteins are transferred to a 
PVDF membrane via a tank blot (3 h at 400 mA or o/n at 180 mA) or a semi-dry-blot system (1-1.5 h 
at 150-200 mA). The transfer is performed at 4°C. The membrane is blocked for 1 h in blocking 
buffer. Subsequently, it is incubated with the primary antibody diluted in blocking buffer for 1 h at RT 
or o/n at 4°C. Then, the membrane is washed 3x 15 min with TBS-T and incubated with the secondary 
antibody diluted in blocking buffer for 30-45 min at RT. After 3x 15 min washing in TBS-T and once 
in TBS, ECL plus solution is applied to the membrane as instructed by the manufacturer. The mem-
brane is rinsed once with TBS. Subsequently it is dried, before detection using a Hyperfilm in the 
Curix developing machine takes place. 
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For semi-quantitative studies, immunoblots are scanned with the BioRad GS-800 Calibrated Den-
sitometer. Therefore, the bands of interest are encircled and subsequent measured by use of Quanti-
tyOne. All statistical results are produced using actin or tubulin bands as a reference. 
 
3.2.4. Histological Techniques 
3.2.4.1. Fixation methods 
PFA/MeOH 
Sitting on cover slips, the targeted cells are washed once with warm D-PBS (37°C). At once, 
4 % PFA (RT) is added to the cells followed by incubation for 2-3 min at RT. The PFA is removed 
and the prefixed cells are washed once with D-PBS (RT). Afterwards, cold MeOH (-20°C) is added to 
the cells. The cover slips are incubated on dry ice or in the freezer (-20°C) for additional 10-15 min. 
After the MeOH is removed, cover slips are allowed to dry for a few seconds and then they are washed 
three times with D-PBS. 
 
PFA 
The cover slips, which carry the targeted cells, are washed once with warm D-PBS (37°C), fixed 
with 4% PFA for 15 min and washed three times with D-PBS (RT). 
 
3.2.4.2. Immunoreactivity assay of fixed cells 
The cover slips carrying the fixed cells are placed into a humid chamber. There they are blocked 
for 1 h with blocking solution A. Afterwards, the cells are incubated for 1 h at RT with the primary 
antibody diluted in blocking solution B. The cover slips are three times washed in 1x PBS and incu-
bated for another 45 min-1 h with the secondary antibody diluted in blocking solution B. After wash-
ing the cells three times in 1x PBS, the cover slips are dunked into Milli-Q and mounted with 
Mowiol+DABCO on a glass slide. 
 
 43 
  
44 
 4. Results 
4.1. Specificity of attached antibodies 
For investigation of the protein expression levels and immunoreactivities, different “new” antibod-
ies were established. Some of them just work in immunoblots, some only in immunostainings and 
others can be used for both. Each of the used antibodies was initially tested in HEK293 cells trans-
fected with the accordant GlyR subunit or KCC2 expression construct. In the following figures, the 
“new” antibodies rb αGlyRa1 (Figure 12A), gt αGlyRa2 (Figure 11A and Figure 12B), gt αGlyRb 
(Figure 11B and Figure 12C) and rb αKCC2-1 (Figure 11C and Figure 12D) are applied to transfected 
HEK cells to demonstrate function and specificity. 
 
A: GlyRa2 
 
B: GlyRb 
 
C: KCC2 
 
Figure 11: HEK cells transfected with the indicated expression construct. Immunoreactivity visualized by A, antibody 
αGlyRa2. B, antibody αGlyRb. C, antibody αKCC2-1. Scale bar=50 µm 
 
αGlyRa2 (gt), αGlyRb (gt) and αKCC2-1 respectively recognize the native proteins (Figure 11). 
αGlyRa1 (rb) was not tested for immunoreactivity because it was only used for immunoblots. Instead, 
the well-characterized antibody mAb2 was used to visualize the GlyRa1 subunit in immunostainings. 
All four presented antibodies recognize the accordant denatured protein in immunoblots (Figure 12). 
The GlyRb subunit exhibits 3-5 different bands (Figure 12C), which indicate different splice variants 
expressed in HEK cells or degradation products. Furthermore, the bands run lower than expected 
(58 kDa) which points to the small fragment of the GlyRb gene (1900 bp) cloned into the pcis vector 
and to degradation. αKCC2-1 recognizes two bands in HEK cell protein extracts (Figure 12D). The 
lower band at about 150 kDa represents the KCC2 monomer (126 kDa), the upper band (above 250 
kDa) represents KCC2 oligomers (e.g dimers or tetramers). 
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B 
 
C 
 
D 
 
Figure 12: Immunoblots from HEK293 cells transfected with the indicated expression construct respectively. A, antibody 
αGlyRa1. B, antibody αGlyRa2. C, antibody αGlyRb. D, antibody αKCC2-1. 
 
The well-characterized antibodies mAb2, mAb4 and mAb7 (Pfeiffer et al. 1984), as well as differ-
ent commercial antibodies, were also used in this thesis. 
 
4.2. Expression profiles of the GlyR subunits 
To characterize the expression of the four GlyR subunits in cultured rat spinal or hippocampal 
neurons respectively, different div stages were investigated. Therefore, the RNA as well as the protein 
levels were determined. After preparation, the cells were cultured for 4, 7, 11, 14, 20, 21 or 28 days. 
Div 28 neurons serve as the adult stage according to GlyR expression. At the indicated stages, the cells 
were lysed and RNA or protein extraction was performed. Afterwards, the RNA was reversely tran-
scribed into cDNA, which then was used for subsequent RT-PCR or RTq-PCR studies. The qualitative 
analysis, indicating the presence of different subunits, was followed by the quantitative study. The 
RTq-PCR results are shown as values normalized to one div stage. Thereby, values achieved from 
div 28 cells were determined as “1”. In the case of the GlyRa2 subunit, the youngest stage (div 4) 
served as the control value because at that time point a cell should contain the biggest amount of 
GlyRa2 transcripts. 
It was not possible to quantify the results of the immunoblot analysis, because the existing anti-
bodies against the GlyR subunits do not work properly when being applied to neuronal protein ex-
tracts. However, some of those blots are shown. 
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4.2.1. Dynamics of GlyR subunit expression in HCNs 
During the analysis of the hippocampal cultures, it appeared that RNA of all GlyR subunits is ex-
pressed without GlyRa1 (Figure 13). The same was already shown via in situ hybridizations of Maria-
Luisa Malosio (Malosio et al. 1991b) and in this thesis confirmed by RT-PCR data. RNA expression 
of the GlyRa2 subunit decreases with development. In contrast, RNA expression of the GlyRb subunit 
remains unchanged. 
 
A: GlyRa1 primer 
 
B: GlyRa2 primer 
 
C: GlyRa3 primer 
 
D: GlyRb primer 
 
Figure 13: RT-PCR from HCN cDNA prepared at the indicated time points. A, GlyRa1 primer. B, GlyRa2 primer. C, 
GlyRa3 primer. D, GlyRb primer. Negative control: Master Mix without cDNA. 
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Additional to the RT-PCR studies, RTq-PCR was performed to calculate the relative changes in 
GlyR subunit RNA expression during in vitro development. The following investigations confirm the 
in situ data of Maria-Luisa Malosio (Malosio et al. 1991b), who also showed, that the RNA level of 
the GlyRa2 subunit decreases during development (Figure 14A). Furthermore, GlyRa3 RNA reaches a 
high peak at div 7 remaining unmatched during the other investigated div stages (Figure 14B). GlyRa3 
RNA expression also increases during the first three weeks in culture compared to div 4 but reaches 
the same state in adulthood (div 28). GlyRb transcripts, in contrast, already show 60% of the adult-
hood level at div 4. During development, the RNA level befalls a slight decrease in order to reach its 
maximum at div 21 and to stay there (Figure 14C). 
 
A 
 
B 
 
C 
 
 
Figure 14: RTq-PCR from HCN cDNA, prepared at the 
indicated time points using TaqMan Gene Expression As-
says. A, GlyRa2 primer. B, GlyRa3 primer. C, GlyRb 
primer. N=3, mean SEM. 
 
Regarding the curves of the three examined GlyR subunits combined in one diagram (Figure 
15A), the GlyRb and GlyRa2 trajectories cross around div 14. To that time point, the mentioned sub-
unit switch is predicted to occur. By generating the reciprocal of the CT values, the absolute RNA 
amounts of the subunits can be compared (Figure 15B). While the GlyRb subunit exhibits the highest 
amount of transcripts even increasing during development, the GlyRa3 subunit only reaches one fourth 
of it. In between them, the GlyRa2 transcript amount is slightly decreasing with time. 
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A 
 
B 
 
Figure 15: RTq-PCR summary. A, relative RNA expression of all GlyR subunits in cultured HCNs. Trajectories cannot be 
set in relation to each other in terms of absolute amount of RNA. B, amount of GlyR subunit RNA, calculated by the recipro-
cal of the CT values. Mean of 3 experiments. 
 
At the protein level, only GlyRa2 and GlyRb subunit could be investigated. Clearly visible is the 
augmentation of the GlyRa2 expression during development (Figure 16A). As well as the GlyRa2 
band, the GlyRb band runs higher than expected. This phenomenon probably results from the impreci-
sion of the prestained protein standard. GlyRb expression is present from the beginning of the exami-
nation and stays until div 28, where it reaches a maximum (Figure 16B, lower bands). 
 
A: GlyRa2 B: GlyRb 
Figure 16: Immunoblots from HCN protein extracts taken at the indicated time points. A, antibody αGlyRa2. B, antibody 
αGlyRb (lower bands). 
 
Since the GlyR is mainly expressed in spinal cord and lower brain regions, GlyR subunit expres-
sion also should be determined in SNs. 
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4.2.2. Dynamics of GlyR subunit expression in SNs 
In contrast to the HCN cultures, the RNA of all GlyR subunits is expressed in the SN cultures 
(Figure 17). The level of GlyRa1 RNA increases within the time course (Figure 17A). The GlyRa2 
and GlyRb RNA expression remains unchanged (Figure 17B and D), whereas that of GlyRa3 exhibits 
small variations (Figure 17C). 
 
A: GlyRa1 primer 
 
B: GlyRa2 primer 
 
C: GlyRa3 primer 
 
D: GlyRb primer 
 
Figure 17: RT-PCR from SN cDNA prepared at the indicated time points. A, GlyRa1 primer. B, GlyRa2 primer. C, GlyRa3 
primer. D, GlyRb primer. Negative control: Master Mix without cDNA. 
 
Regarding the semi-quantitative study, the increase of the GlyRa1 RNA level (Figure 18A) re-
minds of the increase in the protein level, shown in the work of Cord-Michael Becker (Becker et al. 
1988). He also demonstrated a decrease of the GlyRa2 protein level. Cord-Michael Becker could dis-
tinguish the two subunits by the size (GlyRa1: 48 kDa, GlyRa2: 49 kDa) using the mAb4 antibody, 
which recognizes all GlyRa subunits. Additionally, this study demonstrates that the RNA levels of the 
GlyRa3 and the GlyRb subunits rise during in vitro development (Figure 18C and D). However, the 
expression patterns of the GlyR subunits differ from each other. The amount of the GlyRa1 RNA re-
mains almost constant until div 14 before it rises erratically (Figure 18A). In contrast, the RNA level 
of the GlyRa3 subunit increases continuously, but steeply (Figure 18C). The GlyRb RNA level also 
increases continuously, but faster (Figure 18D). The adult stage is achieved one week earlier compared 
to the other subunits. During the first week in culture the GlyRa2 subunit RNA level remains similar, 
and then it decreases, rests for another week and reaches the minimum level during the last week be-
fore adulthood (Figure 18B). 
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A 
 
B 
 
C 
 
D 
 
Figure 18: RTq-PCR from SN cDNA, prepared at the indicated time points using TaqMan Gene Expression Assays. A, 
GlyRa1 primer. B, GlyRa2 primer. C, GlyRa3 primer. D, GlyRb primer. N=4, mean  SEM. 
 
Figure 19A impressively clarifies the GlyR subunit switch. The GlyRa1 and GlyRa2 curves cross 
at div 15 indicating the switch to occur at this point. It also shows that GlyRa3 subunit expression 
increases together with the GlyRa1 subunit, but is slightly shifted backwards. By generating the recip-
rocal of the CT, values the absolute RNA amounts of the four investigated subunits can be compared 
(Figure 19B). One can observe that from the beginning most of the transcripts exist of the GlyRb sub-
unit. This subunit already seems to be important at early div stages. At the beginning of the measure-
ment, there is more GlyRa1 RNA than GlyRa3 RNA, but until adulthood, the ratio is surprisingly in-
verted (Figure 19B). The GlyRa2 RNA curve shows the mentioned jump between div 7 and div 14 
(Figure 19A and B). However, in adulthood, more GlyRa2 material than GlyRa1 or GlyRa3 RNA 
remains in the cells (Figure 19B). 
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A B 
Figure 19: RTq-PCR summary. A, relative RNA expression of all GlyR subunits in cultured SNs. Trajectories cannot be set 
in relation to each other in terms of absolute amount of RNA. B, amount of GlyR subunit RNA calculated by the reciprocal 
of the CT values. Mean of 4 experiments. 
 
At the protein level, GlyRa2 is present from the first investigated div stage and stays until adult-
hood (div 28, Figure 20A). GlyRb expression also starts not later than div 7, increases during devel-
opment but then decreases until adulthood (Figure 20B). 
 
A B 
Figure 20: Immunoblots from SN protein extracts taken at the indicated time points. A, antibody αGlyRa2. B, antibody 
αGlyRb (lower bands). 
 
The ion transporter KCC2 is up regulated in the rat brain during development (Lu et al. 1999). Be-
cause this transporter is essential for inverting the extra- versus the intracellular chloride ratio, its ex-
pression dynamics in spinal cord also were investigated. 
4.3. Characterization of the KCC2 expression in spinal neurons 
The ion transporter KCC2 plays an important role during neuronal development. KCC2 is respon-
sible for changing the ion ratio inside the cell versus the extracellular space. Its function thereby is, to 
reduce the intracellular chloride level by expelling chloride ions together with potassium ions out of 
the cell. In contrast to the juvenile stage, more chloride ions are located extracellularly than inside the 
cell in adulthood. If a chloride channel in the latter stage is opened by a neurotransmitter, chloride 
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does no longer flow out of the cell but rather into the cell. This directs a hyperpolarisation of the post-
synaptic cell instead of a depolarisation. To investigate the contribution of KCC2 expression to the 
subunit switch, in situ and in vitro protein and RNA expression studies were performed. 
As expected, the expression of KCC2 RNA increases during development. Thereby, the amount of 
transcripts is approximately duplicated (Figure 21A). 
At the protein level, there also is an increase of KCC2 expression during development. However, 
the protein amount reaches its maximum at div 14 and subsequently decreases to a lower level (Figure 
21B). The in situ data show a similar pattern, but the maximum expression is achieved at P 22 (Figure 
21C). 
 
A: in vitro 
 
 
Figure 21: KCC2 expression in spinal neurons. A, relative 
KCC2 RNA expression in cultured SNs. N=6, mean  SEM. 
B, endogenous KCC2 protein expression in SN cultures 
(upper panel) and actin control (lower panel). C, endoge-
nous KCC2 protein expression in spinal cord homogenates. 
RNA extracts, protein extracts and homogenates are taken at 
the indicated time points. 
B: in vitro 
 
C: in situ 
 
 
The next step was to check if blockade of glycinergic transmission alters the expression of KCC2 
and the GlyR subunits and therewith the subunit switch. 
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4.4. Altered expression of GlyR subunits and KCC2 upon blockade 
of glycinergic transmission and Ca2+ influx 
The first idea, after characterization of the GlyR subunit and KCC2 expression dynamics in devel-
opment, was to block glycinergic transmission by strychnine application. Therefore spinal neurons 
were cultured as described and 1µmol/l strychnine was added three times a week beginning at div 1. 
The following immunoblots gave an initial impression of upcoming effects. Comparing protein ex-
tracts of untreated (Figure 22A) and treated cultures (Figure 22B), KCC2 expression seems to be down 
regulated in cultures with impaired glycinergic transmission. 
 
A: control 
 
B: strychnine treated 
 
Figure 22: Endogenous KCC2 (upper panels) and actin (lower panels) expression in SN cultures. A, untreated cells. B, cells 
treated with 1 µM strychnine. Protein extracts were taken at the indicated time points. 
 
Towards this finding a dose-response assay using different strychnine concentrations was per-
formed. Three trials of three different time points respectively were produced and the data were quan-
tified (Figure 23). Cells were treated as described above. Only at div 14, a significant dose-dependent 
decrease in KCC2 expression arises (Figure 23A and D). 
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B: div 4 
 
A 
C: div 7 
 
Figure 23: Effect of strychnine application to SN cultures 
onto KCC2 expression. A, endogenous KCC2 and actin 
expression in SN cultures treated with the indicated concen-
trations of strychnine. B, C, D, semi-quantitative determina-
tion of KCC2 expression in treated SNs at div 4 (B), div 7 
(C) and div 14 (C). N=3, ANOVA: mean  s.d., p<0.05*. 
D: div14 
 
The resulting question was, if the reduction in KCC2 expression arises from the lacking glyciner-
gic transmission or from reduced Ca2+-influx into the cells. To determine these considerations, differ-
ent inhibitors were applied to the SN cultures. First, 1 µmol/l TTX was applied twice a week to com-
pletely abolish transmission. Application of TTX leads to a significant decrease in KCC2 and mAb7 
expression (Figure 24A and B). GlyR subunits were not concerned. To block Ca2+-signalling, 
10 µmol/l BAPTA was added to the cultures. BAPTA is able to enter the cells and therefore can form 
complexes with the entire free Ca2+ in the cultures. Cells were incubated for one night with BAPTA 
before they were lysed. BAPTA altered the KCC2 expression and to a small extent GlyRa expression 
(mAb4) but not gephyrin expression (mAb7). This treatment was done once and not quantified be-
cause the phenomenon of Ca2+-influx should be investigated and not the presence of Ca2+ inside the 
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cell. Furthermore, to check if blockade of other ion channels affects KCC2 expression different inhibi-
tors were applied to SNs (Figure 24C). To block NMDAR activity, AP5 (30 µmol/l) and mk801 
(5 µmol/l) were used; cnqx (20 µmol/l) blocks AMPAR while GABAAR is blocked by gabazine 
(10 µmol/l) or bicuculline (20 µmol/l). All inhibitors were added three times a week. The activity of 
none of these receptors seems to be important for KCC2 expression without gabazine, which leads to 
an increase in KCC2 expression. Gephyrin expression seems to be decreased to a small extent upon 
inhibiting activity of excitatory receptors. Interestingly, only mAb7 signal exhibits this effect, the 408 
signal remains unchanged. GlyRa subunit expression possibly is up regulated upon GABAAR block-
ade. However, these findings were not investigated further. 
 
B 
 
A 
 
Figure 24: Endogenous KCC2, GlyRa, gephyrin and actin 
expression in div 15 SN cultures. A, cells treated with TTX 
and BAPTA. B, semi-quantitative determination of bands 
obtained in A. N=3, mean  s.d., two-tailed ttest: p<0.01**, 
p<0.001***. C, cells treated with the indicated inhibitors. 
C 
 
 
In addition, different blockers for Ca2+-channels were used. EGTA binds the entire free Ca2+ of the 
medium but is not able to enter the cell. EGTA (5 mmol/l) as well as verapamil (1 µmol/l) and nifedip-
ine (20 µmol/l) were applied the day before lysates were taken (Figure 25A). KCC2 expression was 
not affected by application of these drugs but interestingly, KCC2 oligomers (KCC2/oligo) were 
formed to a significant higher extent (Figure 25B). Because mAb7 signal completely is abolished upon 
EGTA application and decreased following BAPTA application (but not 408 signal, Figure 25A), it 
may be that gephyrin is modified by e.g. phosphorylation. This implies mAb7 to be a phosphorylation-
specific antibody. To check this consideration, the phosphorylation-specific antibody Phospho-S6 
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Ribosomal Protein (P-S6) was applied to the immunoblot. In fact, the signal was decreased or almost 
completely abolished in EGTA- and BAPTA-treated cultures (Figure 25C). Therefore, it is highly 
probable that mAb7 is phospho-specific and that loss of free Ca2+ affects the phosphorylation states of 
certain proteins such as gephyrin. Thus, the activity of kinases and/or phosphatases might be con-
cerned. At least, KCC2 oligomers seem to be dependent on either phosphorylation or another influ-
ence arisen by Ca2+. 
 
B 
 
A 
Figure 25: Endogenous KCC2, GlyRa, gephyrin, P-S6 and 
actin expression in div 15 SN cultures. A, cells treated with 
the indicated inhibitors/chelator. B, semi-quantitative de-
termination of the EGTA experiments obtained in A. N=3, 
mean  s.d., two-tailed ttest: p<0.05*, p<0.001***. C, cells 
treated with the indicated inhibitor/chelators. 
C 
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Subsequently, the opposite effect should be achieved by treating cells grown in glycine-free me-
dium with 2 mmol/l glycine over night. Cells grown in NB++++ as well as cells grown in glycine-free 
NB++++ served as controls. The expectation was an increased KCC2 expression in glycine treated or 
glycine-containing cells compared to cells grown in glycine-free medium. Unfortunately, this specula-
tion was not confirmed (Figure 26). 
 
A 
 
B 
 
Figure 26: Glycine treatment. A, 
endogenous KCC2 and actin expres-
sion in div 4, 7 and 15 SN cultures 
kept in NB++++ (con), glycine-free 
NB++++ (Gly-free) or glycine-free 
NB++++ and treated with glycine over 
night (Gly-free/+Gly). B, semi-
quantitative determination of A. N=3, 
mean  s.d. ANOVA. 
 
At the end, the assumption came up that not only GlyR activity influences KCC2 expression but 
rather KCC2 expression or activity influences GlyR expression or even the subunit switch. Therefore, 
the next step was to knock down KCC2 expression and analyze the upcoming effects. 
 
4.5. Effects of KCC2 Knockdown 
To test whether KCC2 influences the subunit switch of the GlyR, its expression in SN cultures 
ought to be silenced by RNA interference (RNAi). RNAi represents a complex process of small RNAs 
of 21-25 nucleotides in length evoking sequence-specific silencing of genetic information. In metazoa 
the silencing can occur either via degradation of the mRNA or translational inhibition. Transcribed in 
the nucleus, the pri-miRNA (primary micro RNA) is first processed by an enzyme called Drosha re-
sulting in the pre-miRNA. Exportin 5 guides the pre-miRNA into the cytoplasm where it is further 
processed by Dicer. Afterwards, the unwound and single-stranded siRNA forms a complex with RISC 
(RNA-induced silencing complex), binds residing in the complex to the targeted mRNA and leads to 
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its degradation or translational repression. In this study, short hairpin RNAs (shRNAs), which belong 
to the siRNAs, were used to evoke KCC2 silencing. Therefore, four different shRNA oligos composed 
of sequences complementary to the KCC2 sequence were designed. 
 
4.5.1. Design of shRNA sequences 
4.5.1.1. Identification of silencing Knockdown-Sequences 
HEK cells were transfected with both, a KCC2 expression construct (KCC2_rn in pEFGP-N3; 
short: KCC2-N3) and the vector pCMV-U6 expressing the accordant shRNAs under the U6 promoter 
(pCMV-U6_KCC2kd, short: KCC2kd). Control cells only were transfected with the KCC2 expression 
construct. Untransfected cells served as an additional control. The immunoblot shows that only the 
constructs KCC2kd2 and KCC2kd3 are able to direct a silencing effect in KCC2 expression (Figure 
27). The other two oligos have no effect. Due to these results, only the KCC2kd2 and KCC2kd3 oligos 
together with the U6 promoter are cut off the pCMV-U6 vector and ligated into the pFSGW vector to 
create lentiviral particles for infecting neurons. 
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Figure 27: Recombinant KCC2 
expression in either untransfected 
HEK293 cells (UT) and HEK cells 
transfected with the indicated con-
structs. A, KCC2 and endogenous 
actin expression. B, quantification of 
the immunoblots shown in A. 
 
Additional to the knockdown constructs, it was necessary to create functional non-silencing se-
quences. 
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4.5.1.2. Determination of non-silencing controls 
As a control additional to uninfected cells, a mismatch construct (KCC2kd2mm) appropriate to the 
most potent knockdown oligo KCC2kd2 was created. The sequence of is similar to that of KCC2kd2 
but contains three mutations. These mismatches avoid binding of the shRNA to the targeted mRNA 
and thus silencing of KCC2. For testing the construct, HEK cells were co-transfected with the expres-
sion construct KCC2-N3 and pCMV-U6_KCC2kd2mm or as a control the empty pCMV-U6 vector. 
Protein extracts of the cells were taken and analyzed via immunoblot (Figure 28). The diagram clearly 
shows that the mismatch sequence is not able to generate a knockdown of KCC2. The KCC2 expres-
sion in cells co-transfected with KCC2kd2mm and KCC2-N3 is as strong as in cells co-transfected 
with KCC2-N3 and pCMV-U6, which serve as control cells. In contrast, KCC2kd2 induces an almost 
complete loss of recombinant KCC2 expression in HEK cells co-transfected with KCC2-N3 (Figure 
28B). 
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Figure 28: Recombinant KCC2 expression in 
either untransfected HEK293 cells (UT) or 
HEK cells transfected with the indicated 
constructs. A, KCC2 and endogenous actin 
expression. B, quantification of the im-
munoblots shown in A. 
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As a rescue control, an expression construct of KCC2-N3 containing three silent mutations com-
pared to the original KCC2-N3 was created. These mutations are localized in exactly the same region 
where the shRNA of KCC2kd2 is able to bind. Occupying these mutations, the so-called KCC2-
N3mut should be resistant against the silencing effect. Indeed, recombinant KCC2 expression, which 
was abolished in cells co-transfected with KCC2kd2 and KCC2-N3, was not affected in cells co-
transfected with KCC2kd2 and KCC2-N3mut (Figure 29). 
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Figure 29: Recombinant KCC2 expression in 
either untransfected HEK293 cells (UT) or 
HEK cells transfected with the indicated 
constructs. A, KCC2 (upper panel) and en-
dogenous actin expression (lower panel). B, 
quantification of the immunoblots shown in A. 
Transfections, SDS-PAGE and immunoblot-
ting were performed by Nicolai Nagelpusch. 
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Unfortunately, it was not possible to clone the KCC2-N3mut sequence into the viral pFSGW vec-
tor in this thesis. Hence, it could not be used as a rescue control in SNs. Nevertheless, the HEK cell 
studies demonstrate that the mutated construct is functional and resistant against the shRNA oligo. As 
shown in immunoblot studies there are no KCC2 or rather GFP immunoreactivities in untransfected 
HEK cells (Figure 30A). Control cells co-transfected with KCC2-N3 and pCMV-U6 exhibit a normal 
GFP and KCC2 signal (Figure 30B), whereas cells co-transfected with KCC2-N3 and KCC2kd2 de-
velop a much lower signal (Figure 30C). Cells co-transfected with KCC2-N3 and KCC2kd2mm reveal 
a normal KCC2 and GFP expression because the mismatch sequence is not able to silence KCC2 ex-
pression (Figure 30D). To demonstrate the normal expression of the mutated construct, cells were co-
transfected with KCC2-N3mut and pCMV-U6 (Figure 30E). At last, cells were co-transfected with 
KCC2-N3mut and KCC2kd2 to show that the shRNA is indeed no longer able to bind to the KCC2 
RNA and thus induce a knockdown of KCC2 expression (Figure 30F). 
Towards these findings in HEK cells, the effects of the lentiviral particles containing the knock-
down sequences onto KCC2 expression in SNs and HCNs ought to be investigated next. 
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A 
GFP 
 
KCC2 GFP (green), KCC2 (red) 
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Figure 30: Recombinant GFP- and KCC2-immunoreactivities in HEK cells. A, untransfected cells. Cells co-transfected with 
KCC2-N3 and pCMV-U6 (B) KCC2-N3 and KCC2kd2 (C), KCC2-N3 and KCC2kd2mm (D), KCC2-N3mut and pCMV-U6 
(E), KCC2-N3mut and KCC2kd2 (F). Scale bar=30 µm. Transfections and images were performed by Nicolai Nagelpusch. 
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4.5.2. Effects of KCC2 knockdown in HCNs and SNs 
For the production of lentiviral particles HEK293T cells were transfected with three different plas-
mids: pFSGW, expressing the shRNA sequence under the synapsin promoter, pVSVG, the envelope 
vector and finally pCMV 8.9, the packaging vector for the virus. Given, that all three constructs are 
expressed in the cell, the virus particles carrying the shRNA are allowed to form and break out of the 
cell. Hence, they are found in the medium, can be isolated and stored at -80°C. SNs as well as HCNs 
were infected with lentiviral particles. Therefore, one aliquot of virus was gently thawed on ice, filled 
with NB to 1 ml final volume (virus suspension) and was added to the medium of the neurons. The 
cells were infected at div 4 and treated with AraC to stop glial proliferation at div 11. The analysis 
took place at div 8, 15, 22 or 36. 
 
4.5.2.1. Effects of KCC2-Knockdown in HCNs 
This short investigation should simply show that the shRNA also induces a down regulation of 
KCC2 in HCNs. Cells were infected as indicated and analyzed at div 20. The experiment was done 
once. A clear knockdown of KCC2 appears in the infected cultures (Figure 31). Gephyrin expression 
seems not to be decreased in the form, antibody 
408 recognizes, but mAb7 signal is reduced. 
This supports the idea that at least two forms of 
gephyrin exist. These two forms probably differ 
in their phosphorylation state. The GlyRa sub-
units also are down regulated. Generally, more 
amount of virus suspension (80 µl) is necessary 
to evoke down regulation of other genes than 
KCC2. 
 
Figure 31: Endogenous KCC2, gephyrin (mAb7 and 408), 
GlyRa (mAb4) and actin expression in div 20 HCNs after 
infection with KCC2kd2. 
Because the GlyR is mainly expressed in 
spinal cord, all following studies were exclu-
sively done using SN cultures. 
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4.5.2.2. Effects of KCC2-Knockdown in SNs 
The effects of the KCC2 knockdown in SNs were examined in much more detail. Cells were in-
fected, treated with AraC and lysed as mentioned above. Immunostainings as well as immunoblots 
were performed. 
 
Semi-quantitative determination of receptor and KCC2 protein 
For the immunoblots, protein extracts were taken at div 15. For the first experiments, uninfected 
cells served as control. Later cells infected with KCC2kd2mm virus were used as control cells. Differ-
ent proteins were tested for altered expression. The first thing to clarify was the existence of the 
knockdown effect and which virus concentration should be used to achieve an optimal silencing effect 
without killing to many cells (Figure 32). Furthermore, mAb4 recognizing all GlyRa subunits, should 
shed light on the effect of KCC2 knockdown onto the GlyR. Indeed, the GlyRa subunit expression 
decreases according to augmented virus concentration (Figure 32). The same is true for gephyrin rep-
resented by the mAb7 antibody. Gephyrin provides the connection of the GlyR to the cytoskeleton 
(Poulopoulos et al. 2009). Interestingly, only mAb7 exhibits that effect, 408 in contrast does not show 
any significant change in expression. Actin was thereby used as loading control and hence for nor-
malization in the statistics  
 
B A 
Figure 32: A, endogenous KCC2, gephyrin (mAb7 and 
408), GlyRa (mAb4) and actin expression in SNs at div 15. 
B, quantification of A. N=4, mean  s.d., two-tailed ttest: 
p<0.05*, p<0.01**, p<0.001***. 
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According to these observations, the question arises if other receptors also are affected by the 
knockdown of KCC2. Expression of NMDAR1 is significantly increased in knockdown cells (Figure 
33). The GlyRa1 subunit expression decreases according to augmenting virus titre but the reduction 
only becomes significant at the highest virus concentration. Expression of the GlyRa2 subunit remains 
unchanged. 
 
B A 
Figure 33: A, endogenous NMDAR1, GlyRa1, GlyRa2 and 
actin expression in SNs at div 15. B, quantification of A. 
N=4, mean  s.d., two-tailed ttest: p<0.05*, p<0.01**, 
p<0.001***. 
 
For immunoreactivity localization, only cells infected with KCC2kd2mm were used as control. There-
fore, it was necessary to determine whether the mismatch sequence evokes significant changes in pro-
tein expression during time. 
 
Determination of receptor and KCC2 protein in control, mismatch  
and knockdown cultures 
To test the possible effects of the mismatch sequence, SNs were infected with KCC2kd2 or 
KCC2kd2mm or remained uninfected. Protein levels of KCC2, GlyRa (mAb4), gephyrin (mAb7 and 
408), GlyRa2 and tubulin were determined at three different time points (div 8, 15 and 22, Figure 
34A). Via semi-quantitative analysis (Figure 34B-D), the relative differences in the protein expression 
levels of infected cells could be compared to uninfected cells (con). 
On the one hand, the analysis clarifies that at all investigated time points the mismatch sequence 
does not evoke any significant changes in protein expression. On the other hand, it becomes clear that 
the effects of the knockdown reach their maximum not before the third week in culture (div 22). The 
down regulation of KCC2 expression remains from div 15 on the lowest level (20% of control and 
mismatch). However, the effects of the knockdown onto the GlyR and gephyrin come in later. Gephy-
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rin expression even is significantly up regulated at div 8. One week later in turn, mAb7 signal is sig-
nificantly decreased. After three weeks in culture finally, GlyR subunits and gephyrin are significantly 
down regulated. The expression of the juvenile GlyRa2 subunit and the 408 signal remain unchanged 
during the whole time of investigation. 
 
B: div 8 A 
C: div 15 
Figure 34: A, endogenous KCC2, GlyRa (mAb4), gephyrin 
(mAb7 and 408), GlyRa2 and tubulin expression in SNs at div 8, 
15 and 22. B, C and D quantifications of A respectively. N=3, 
mean  s.d., two-tailed ttest: p<0.05*, p<0.01**, p<0.001***. 
con: uninfected cells, mm: cells infected with KCC2kd2mm, kd2: 
cells infected with KCC2kd2. 
D: div22 
 
After these immunoblot studies, the GlyR subunits and some other synaptic markers should be 
shown as immunoreactivities in fixed cells. A more pronounced effect is expected from those studies 
because thereby it is possible to discriminate between infected and uninfected cells via GFP expres-
sion. In immunoblot studies, the results consist of a mixture of infected and uninfected cells. 
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Localization of immunoreactivities 
For visualizing the GlyRa subunits, antibody mAb4 was used. MAb2 specifically stains GlyRa1 
clusters and mAb7 represents gephyrin. Moreover, GlyRa2, GABAAR, KCC2, GFP, PSD 95 and 
VIAAT were visualized. Illustration of KCC2 sheds light on the knockdown efficiency, GFP signal 
reveals infected cells, PSD°95 serves as a control for synaptic proteins being independent of the GlyR 
complex and VIAAT gives information about the presynaptic component. First, infection of the cells 
and an efficient knockdown of KCC2 ought to be confirmed. 
 
Verification of Infection and KCC2 Knockdown 
To show cells carrying the virus, cultures were stained for GFP. Because the pure green signal of 
the infected and thus GFP expressing cells was too low, the GFP signal was additionally amplified by 
a well working FITC-conjugated GFP antibody. Information about a KCC2 knockdown evoked by 
KCC2kd2 but not by KCC2kd2mm gave the KCC2-1 antibody. Indeed, the cells of the mismatch cul-
tures were infected (green) and KCC2 positive (red) at the same time. However, cells infected by 
KCC2kd2 virus do not exhibit normal or rather any KCC2 expression. For the statistical analysis, 11-
12 pictures of GFP-positive cells were taken per culture. Subsequently the numbers of GFP-positive, 
KCC2-positive and both, GFP- and KCC2-positive cells were determined. For all three investigated 
time points (div 15, 22 and 36) the same effect appears. There is no significant difference in the num-
ber of GFP-positive cells between the two conditions. However, significant differences appear in the 
number of KCC2-positive cells and in the number of both KCC2- and GFP-positive cells (Figure 35, 
Figure 36 and Figure 37). Below, representing cells are shown. 
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Figure 35: GFP- and endogenous KCC2-immunoreactivity in div 15 SNs. A, cells infected with KCC2kd2mm. B, cells 
infected with KCC2kd2. C, quantification of mismatch (black bars) and knockdown (gray bars) cultures. N=4, mean  s.d., 
two-tailed ttest: p<0.001***, scale bar=30 µm. 
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Figure 36: GFP- and endogenous KCC2-immunoreactivity in div 22 SNs. A, cells infected with KCC2kd2mm. B, cells 
infected with KCC2kd2. C, quantification of mismatch (black bars) and knockdown (gray bars) cultures. N=4, mean  s.d., 
two-tailed ttest: p<0.01**, scale bar=30 µm. 
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Figure 37: GFP- and endogenous KCC2-immunoreactivity in div 36 SNs. A, cells infected with KCC2kd2mm. B, cells 
infected with KCC2kd2. C, quantification of mismatch (black bars) and knockdown (gray bars) cultures. N=4, mean  s.d., 
two-tailed ttest: p<0.001***, scale bar=30 µm. 
 
After infection and knockdown confirmation, the next step was to investigate effects of the KCC2 
knockdown onto the GlyR subunits. 
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Effects of KCC2 knockdown onto the GlyR alpha subunits 
To achieve a first impression, cells were stained with mAb4 to examine if the knockdown has a 
general effect on the GlyR. Typical cells, such as used for the statistics, are presented below. For 
quantitative measurements, 11-12 images per culture were taken. Afterwards, regions of interest 
(ROIs) being 30 µm of dendrite next to the soma were determined and analyzed. Therefore, all puncta 
within the ROIs were scanned for their number, size (µm²) and gray value (fluorescence intensity). Per 
cell, all dendrites were recorded if possible. Background region was determined and thus subtracted 
from the signal for all pairs of mismatch and knockdown cultures individually. The following images 
are results of 4 independent experiments. At div 15, significant differences in number, size and gray 
value of GlyRa puncta occur (Figure 38). 
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Figure 38: GFP- and endogenous GlyRa-immunoreactivity 
in div 15 SNs. A, cells infected with KCC2kd2mm. B, cells 
infected with KCC2kd2. C, D and E, quantification of the 
number (C), the size (D) and the gray value (E) of GlyRa 
puncta. N=4, mean  s.d., two-tailed ttest: p<0.05*, 
p<0.01**, scale bar=30 µm. 
 
These results reveal that there are less GlyRa clusters in knockdown cultures. The remaining clus-
ters are smaller and glow weaker than cells of the mismatch control. 
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At div 22, mismatch and knockdown cultures also differ significantly in all three categories 
(Figure 39). 
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Figure 39: GFP- and endogenous GlyRa-immunoreactivity 
in div 22 SNs. A, cells infected with KCC2kd2mm. B, cells 
infected with KCC2kd2. C, D and E, quantification of the 
number (C), the size (D) and the gray value (E) of GlyRa 
puncta. N=4, mean  s.d., two-tailed ttest: p<0.05*, 
p<0.001***, scale bar=30 µm. 
 
 
 
74 
Results 
Even towards five weeks in culture, the knockdown still is intact and directs significant alterations 
of the observed parameters (Figure 40). 
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Figure 40: GFP- and endogenous GlyRa-immunoreactivity 
in div 36 SNs. A, cells infected with KCC2kd2mm. B, cells 
infected with KCC2kd2. C, D and E, quantification of the 
number (C), the size (D) and the gray value (E) of GlyRa 
puncta. N=4, mean  s.d., two-tailed ttest: p<0.05*, scale 
bar=30 µm. 
 
According to these observations, the effects ought to be specified more precisely. Therefore, the 
adult and the juvenile GlyRa subunits respectively were investigated. 
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Effects of KCC2 knockdown onto the adult GlyRa1 subunit 
Since immunoblots already had shown that the adult GlyRa1 subunit is expressed to a lower level 
in knockdown cultures, its proportion was examined first. Antibody mAb2 is able to detect the adult 
GlyRa1 subunit specifically. The effect should turn out stronger compared to the mAb4 results, be-
cause the presumably unaltered contribution of the GlyRa2 subunit is abolished. Actually, this obser-
vation is made at div 15. Cells carrying the knockdown construct form less, smaller and weaker glow-
ing clusters than the cells of the mismatch cultures (Figure 41). 
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Figure 41: GFP- and endogenous GlyRa1-immunoreactivity 
in div 15 SNs. A, cells infected with KCC2kd2mm. B, cells 
infected with KCC2kd2. C, D and E, quantification of the 
number (C), the size (D) and the gray value (E) of GlyRa1 
puncta. N=4, mean  s.d., two-tailed ttest: p<0.05*, 
p<0.01**, scale bar=30 µm. 
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One week later in culture, the effects still are existent (Figure 42). 
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Figure 42: GFP- and endogenous GlyRa1- immunoreactiv-
ity in div 22 SNs. A, cells infected with KCC2kd2mm. B, 
cells infected with KCC2kd2. C, D and E, quantification of 
the number (C), the size (D) and the gray value (E) of 
GlyRa1 puncta. N=5, mean  s.d., two-tailed ttest: p<0.05*, 
p<0.001***, scale bar=30 µm. 
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Towards five weeks in culture, there is no longer a difference in the gray value of GlyRa1 puncta 
between mismatch and knockdown cells. Nevertheless, there still is a less pronounced effect in the 
number and the size of the GlyRa1 clusters (Figure 43). 
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Figure 43: GFP- and endogenous GlyRa1-immunoreactivity 
in div 36 SNs. A, cells infected with KCC2kd2mm. B, cells 
infected with KCC2kd2. C, D and E, quantification of the 
number (C), the size (D) and the gray value (E) of GlyRa1 
puncta. N=4, mean  s.d., two-tailed ttest: p<0.05*, scale 
bar=30 µm. 
 
Obviously, the expression of the GlyRa1 subunit is seriously altered by knocking down KCC2 ex-
pression. It is examined as follows, whether, as in immunoblots suggested, the GlyRa2 subunit is not 
concerned by these alterations. 
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Effects of KCC2 knockdown onto the juvenile GlyRa2 subunit 
To test, whether knockdown of KCC2 has consequences for the expression of the GlyRa2 subunit, 
the protein was detected by use of an antibody made in goat. The only secondary antibody giving a 
cross reaction-free signal was αgt-cy2. Hence, the infected cells cannot be identified. Instead, only 
KCC2-positive cells were imaged in mismatch cultures and KCC2-negative cells were imaged in 
knockdown cultures. Therefore, it has to be assumed that also few uninfected cells contribute to the 
statistics. 
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Figure 44: GFP- and endogenous GlyRa2- immunoreactiv-
ity in div 15 SNs. A, cells infected with KCC2kd2mm. B, 
cells infected with KCC2kd2. C, D and E, quantification of 
the number (C), the size (D) and the gray value (E) of 
GlyRa2 puncta. N=4, mean  s.d., two-tailed ttest, scale 
bar=30 µm. 
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Immunoblot analysis implies the juvenile GlyRa2 subunit not to be concerned by the knockdown. 
Indeed, there are no significant differences between the mismatch and knockdown cultures at div 15 
(Figure 44). 
At div 22, an unexpected significant decrease in the number of GlyRa2 clusters in knockdown cul-
tures occurs (Figure 45C). The other parameters do not exhibit any alteration (Figure 45D and E). 
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Figure 45: GFP- and endogenous GlyRa2- immunoreactiv-
ity in div 22 SNs. A, cells infected with KCC2kd2mm. B, 
cells infected with KCC2kd2. C, D and E, quantification of 
the number (C), the size (D) and the gray value (E) of 
GlyRa2 puncta. N=4, mean  s.d., two-tailed ttest: p<0.05*, 
scale bar=30 µm. 
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At div 36, the number of GlyRa2 clusters in mismatch and knockdown cultures does no longer ex-
hibit any significant difference (Figure 46C). Furthermore, the size and the gray value of GlyRa2 clus-
ters remain unchanged (Figure 46D and E). 
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Figure 46: GFP- and endogenous GlyRa2- immunoreactiv-
ity in div 36 SNs. A, cells infected with KCC2kd2mm. B, 
cells infected with KCC2kd2. C, D and E, quantification of 
the number (C), the size (D) and the gray value (E) of 
GlyRa2 puncta. N=3, mean  s.d., two-tailed ttest, scale 
bar=30 µm. 
 
As previously indicated, gephyrin, comprising an anchoring function for the GlyR complex, also 
exhibits a diminished expression evoked by KCC2 knockdown. Thus, the immunoreactivity is deter-
mined as well. 
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Effects of KCC2 knockdown onto gephyrin expression 
As shown in various publications, the GlyRb subunit owns a binding site for the anchor protein 
gephyrin. Gephyrin forms a lattice-like structure underneath the membrane to which the GlyRb sub-
unit is allowed to bind (Poulopoulos et al. 2009). Since the GlyR appears to form hetero-oligomers 
consisting of GlyRa1 and GlyRb subunits, it might be obvious, that together with the decrease in 
GlyRa1 expression, gephyrin expression is diminished as well (Figure 47). However, due to the small 
differences in GlyRa2 expression one cannot suggest less gephyrin expression. That subunit forms 
amongst others homo-oligomers and does not necessarily bind to gephyrin. Immunoblots already dem-
onstrated a drop of the gephyrin expression in knockdown cultures revealed by mAb7 detection. 
MAb7 exhibits rounded structures within the cultures. These patterns are presumably glial cell nuclei. 
This characteristic nuclei stain of mAb7 is well known. 
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Figure 47: GFP- and endogenous gephyrin-
immunoreactivity in div 15 SNs. A, cells infected with 
KCC2kd2mm. B, cells infected with KCC2kd2. C, D and E, 
quantification of the number (C), the size (D) and the gray 
value (E) of gephyrin puncta. N=4, mean  s.d., two-tailed 
ttest: p<0.05*, p<0.01**, scale bar=30 µm. 
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The effect still is present one week later in development (Figure 48). The knockdown cultures ex-
hibit diminished values in two parameters (Figure 48C and D). The remaining clusters in knockdown 
cells do not exhibit a weaker fluorescence than clusters of mismatch cells anymore (Figure 48E). 
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Figure 48: GFP- and endogenous gephyrin-
immunoreactivity in div 22 SNs. A, cells infected with 
KCC2kd2mm. B, cells infected with KCC2kd2. C, D and E, 
quantification of the number (C), the size (D) and the gray 
value (E) of gephyrin puncta. N=4, mean  s.d., two-tailed 
ttest: p<0.05*, p<0.001***, scale bar=30 µm. 
 
84 
Results 
 
Not until five weeks in culture, the observed effects start to neutralize. The differences between 
knockdown and mismatch cells become smaller at this point (Figure 49D and E). The only remaining 
significant effect is found in the number of clusters (Figure 49C). 
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Figure 49: GFP- and endogenous gephyrin-
immunoreactivity in div 36 SNs. A, cells infected with 
KCC2kd2mm. B, cells infected with KCC2kd2. C, D and E, 
quantification of the number (C), the size (D) and the gray 
value (E) of gephyrin puncta. N=4, mean  s.d., two-tailed 
ttest: p<0.05*, scale bar=30 µm. 
 
Additional to the GlyR subunits and gephyrin, other synaptic proteins were examined to exclude a 
general loss of synapses or shrinking of synapses. This should restrict the effect to the GlyR. 
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Effects of KCC2 knockdown on PSD 95 expression 
The next explored protein was PSD 95. This neuron-specific protein assembles underneath the 
postsynaptic membrane where it forms scaffolds for anchoring synaptic receptors such as AMPARs or 
NMDARs. It is not shown to interact with the GlyR. At div 15, no obvious alterations in the taken 
parameters are present (Figure 50). Indeed the standard deviation in all trials is very high suggesting a 
quite variable expression of this protein. 
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Figure 50: GFP- and endogenous PSD95-immunoreactivity 
in div 15 SNs. A, cells infected with KCC2kd2mm. B, cells 
infected with KCC2kd2. C, D and E, quantification of the 
number (C), the size (D) and the gray value (E) of PSD 95 
puncta. N=4, mean  s.d., two-tailed ttest, scale bar=30 µm. 
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One week later, still no significant differences between the two conditions occur (Figure 51). The 
variability within the trials remains high. However, based on these data, one can conclude that the 
number and the size of the PSD 95 puncta increase during synaptogenesis and decrease in turn after 
termination of synaptogenesis. 
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Figure 51: GFP- and endogenous PSD95-immunoreactivity 
in div 22 SNs. A, cells infected with KCC2kd2mm. B, cells 
infected with KCC2kd2. C, D and E, quantification of the 
number (C), the size (D) and the gray value (E) of PSD 95 
puncta. N=4, mean  s.d., two-tailed ttest, scale bar=30 µm. 
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At the last proved time point (div 36) no significant differences between mismatch and knock-
down cells appear as well (Figure 52). 
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Figure 52: GFP- and endogenous PSD95-immunoreactivity 
in div 36 SNs. A, cells infected with KCC2kd2mm. B, cells 
infected with KCC2kd2. C, D and E, quantification of the 
number (C), the size (D) and the gray value (E) of PSD 95 
puncta. N=4, mean  s.d., two-tailed ttest, scale bar=30 µm. 
 
After demonstrating that a GlyR independent synaptic protein is not concerned by the KCC2 
knockdown, the next interesting step was to investigate the second inhibitory receptor type in the 
CNS, namely GABAAR. 
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Effects of KCC2 knockdown on GABAAR expression 
To test whether the effects caused by KCC2 knockdown in SNs are true for both inhibitory recep-
tors or exclusively for the GlyR, the GABAAR expression was investigated, too. The GABAAR mainly 
is expressed in higher brain regions such as cortex, hippocampus, cerebellum, basal ganglia and 
thalamus, but low expression remains in the spinal cord (Dumoulin et al. 2000). For these studies, the 
antibody GABAAR bd17, which recognizes both the 2 and the 3 subunit of the GABAAR, was used. 
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Figure 53: GFP- and endogenous GABAAR -
immunoreactivity in div 22 SNs. A, cells infected with 
KCC2kd2mm. B, cells infected with KCC2kd2. C, D and E, 
quantification of the number (C), the size (D) and the gray 
value (E) of GABAAR puncta. N=4, mean  s.d., two-tailed 
ttest, scale bar=30 µm. 
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However, bd17 was not able, to detect of any useful signal at div 15. Hence, this study starts not 
until div 22. As in the preceding PSD 95 investigation, there is no detectable difference in any parame-
ter between the two conditions at div 22 (Figure 53). 
Towards five weeks in culture, cells develop less puncta. A significant decrease in the number of 
GABAAR clusters in knockdown cells compared to mismatch cells occurs (Figure 54). The other two 
parameters remain unchanged. 
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Figure 54: GFP- and endogenous GABAAR -
immunoreactivity in div 36 SNs. A, cells infected with 
KCC2kd2mm. B, cells infected with KCC2kd2. C, D and E, 
quantification of the number (C), the size (D) and the gray 
value (E) of GABAAR puncta. N=4, mean  s.d., two-tailed 
ttest: p<0.05*, scale bar=30 µm. 
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After determining the expression of all the postsynaptic proteins, the presynaptic component 
should be investigated as well. 
 
Effects of KCC2 knockdown on VIAAT expression 
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Figure 55: GFP- and endogenous VIAAT -
immunoreactivity in div 15 SNs. A, cells infected with 
KCC2kd2mm. B, cells infected with KCC2kd2. C, D and E, 
quantification of the number (C), the size (D) and the gray 
value (E) of VIAAT puncta. N=3, mean  s.d., two-tailed 
ttest, scale bar=30 µm. 
 
After investigating different postsynaptic proteins, mainly receptors, it also was necessary to look 
at the presynaptic component. Therefore, VIAAT expression was determined in the noted assay. 
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VIAAT is a transmembrane protein storing GABA and glycine in synaptic vesicles. KCC2 knockdown 
does not lead to any effect in VIAAT expression at div 15 (Figure 55). 
After three weeks in culture, no significant effect between mismatch and knockdown cultures can 
be determined (Figure 56). This implicates that KCC2 knockdown does not alter the presynaptic com-
ponent. 
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Figure 56: GFP- and endogenous VIAAT -
immunoreactivity in div 22 SNs. A, cells infected with 
KCC2kd2mm. B, cells infected with KCC2kd2. C, D and E, 
quantification of the number (C), the size (D) and the gray 
value (E) of VIAAT puncta. N=3, mean  s.d., two-tailed 
ttest, scale bar=30 µm. 
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93 
It was not possible to quantify VIAAT immunoreactivity at div 36 because at that time point too 
many and large VIAAT puncta aroused. Thus, the VIAAT study had to end with div 22 data. 
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 5. Discussion 
5.1. Specificity of attached antibodies 
Upon longer exposure of the hyperfilm to the membrane (3 min versus 30 sec.) the αGlyRa1 (rb) 
antibody also exhibits weak bands in the lanes containing lysates of HEK cells transfected with 
GlyRa2 and GlyRa3 subunits. This indicates that αGlyRa1 is also able to bind the other GlyR subunits 
to a small extent. Nevertheless, the latter antibody was used for semi-quantitative studies, because 
after analysis of the data, the results were different from mAb4 data. MAb4 is the antibody recogniz-
ing all α subunits. αGlyRa2 (gt) is clearly specific for the GlyRa2 subunit. The immunoblot signal is 
exclusively found in the GlyRa2 lane and immunoreactivity experiments were well defined. The only 
disadvantage of using this antibody was that it could only be detected using a cy2-conjugated secon-
dary antibody resulting in a green signal. Usually, cells infected with lentivirus were detected by their 
green appearance because they hold a GFP reporter gene, which in turn had to be enhanced by an ad-
ditional antibody staining. Therefore, in cultures stained with αGlyRa2, it was not possible to distin-
guish between infected and non-infected cells. Thus, the quantification of those cultures includes non-
infected cells. Data resulting from the work with αGlyRb were not quantified. 
 
5.2. Expression profiles of the GlyR subunits 
As shown before (Malosio et al. 1991b), mRNA of the GlyRa1 subunit is not present in hippo-
campal neurons. This phenomenon was now confirmed by RTq-PCR data. The achieved GlyRa1 CT 
values differ strongly and are relative high, indicating an extreme late start of amplification. Together, 
the results point to a lack of GlyRa1 mRNA in the hippocampus at the investigated time points. Simi-
lar to Malosio’s data the mRNA level of the GlyRa2 subunit decreases with time. This is already visi-
ble in the RT-PCR studies and later clarified in RTq-PCR experiments. Therefore, it seems that in 
hippocampal neurons potentially a switch in the assembly of the GlyR occurs. Thereby, the GlyRa2 
subunit cannot be replaced by the GlyRa1 subunit but rather by GlyRa3 or another GlyR alpha subunit 
being expressed instead of GlyRa2. The most probable explanation could be that in hippocampus most 
of the GlyRs consist of α2 and  subunits in adulthood. The existence of α2 heteromeric GlyRs has 
been indicated in some studies (Haverkamp et al. 2004, Veruki et al. 2007, Takahashi et al. 1992). 
Arguments for this assumption are the increasing amount of GlyRb subunit and the slight decrease of 
GlyRa2 RNA levels. It seems that in early development, α2 homomeric GlyRs but also (to a lower 
extent) α2 GlyRs are expressed in the hippocampus. During development, the number of α2 GlyRs 
might increase whereas the number of α2 homomeric GlyRs might decrease. As the ratio of α and 
 subunits is determined to 2:3, the bigger amount of GlyRb RNA can be explained. However, one 
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could assume that either the RNA level of GlyRb has to be one third higher than that of GlyRa2 im-
plying only heteromeric receptors in adulthood or even the same or lower regarding the remaining 
homomeric α2 receptors. This problem is solved by the GlyRb subunit also forming heteromeric re-
ceptors with the α3 subunit. 
According to the relative amount, the RNA data are further confirmed by the protein levels. The 
immunoblots show that more GlyRb than GlyRa2 material is present in hippocampal cultures. Also 
fitting with the RNA data is the fact, that GlyRb protein level is decreasing before it is augmented 
shortly prior achieving adulthood. In contrast, the immunoblot suggests GlyRa2 protein level also to 
be increased during development not matching with the RNA data. This might point to another 
thought. Maybe there are more α2 homomeric receptors present in the adult hippocampus than sug-
gested or/and the GlyRa2 subunit is more stable in the membrane and therefore less RNA is needed in 
adulthood. 
In terms of spinal neurons, all four subunits are present at the investigated time points. Yet the RT-
PCR studies show that the amount of GlyRa1 RNA is increasing during development. The other sub-
units do not exhibit big changes. In contrast, the RTq-PCR studies clearly show the augmenting ex-
pression levels of the GlyRa1, GlyRa3 and GlyRb subunit as well as the decrease of GlyRa2 RNA 
expression during development. The juvenile GlyRa2 subunit is likely to be replaced by the GlyRa1 
subunit. This thought is clarified by the cross of the two curves around div 15. The very early up regu-
lation of GlyRb RNA and GlyRa3 RNA also being up regulated but shifted backwards compared to 
GlyRa1, argue for the preferred formation of heteromeric α1 and α3 GlyRs. The number of hetero-
meric α2 and homomeric α2 GlyRs seems to become smaller during the investigated time period. 
The amount of GlyRb RNA is similar to that in HCNs. From div 4 on, GlyRb reaches the highest level 
compared to the other subunits. At the last investigated time point (div 28), GlyRb shows almost twice 
the amount of the GlyRa subunits. Surprisingly, in adulthood GlyRa2 RNA still is the most frequent 
α subunit expressed in SNs. This phenomenon leads to the conclusion that in adulthood probably a 
mixture of heteromeric α1, α2 and α3 GlyRs are expressed as well as presumptive α2 homomeric, 
non-synaptic receptors. 
The immunoblot studies are not meaningful. GlyRa2 protein level seems not to be changed during 
the time window and GlyRb protein bands are hardly recognizable. It seems that the GlyRb protein 
level arises until div 21 and decreases in turn between div 21 and div 28. Since the αGlyRb antibody 
did not continue to work properly, the immunoblot data are not trustworthy. 
 
5.3. Characterization of KCC2 expression in spinal neurons 
As shown in previous studies, KCC2 is up regulated during development (Clayton et al. 1998, Lu 
et al. 1999). In this study, KCC2 RNA expression reaches the highest value at div 21 in vitro but the 
protein level achieves a peak already at div 14. The peak of the protein level at div 14 indicates the 
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highest amount of KCC2 being present around the time point of the developmental switch. The shift 
between protein and RNA level of one week is hardly to explain. It may be, that the turnover rate of 
KCC2 protein becomes faster after the ion ratio within the cell has been changed and so the RNA level 
still is augmented while the protein level already is declining. In contrast, it is obvious, that after turn-
ing the ion ration within the cell, KCC2 can act slower and therefore less protein is sufficient. In 
adulthood, the ion rate just has to be maintained and not be changed any more, requiring less activity. 
Therefore, KCC2 protein and RNA levels are lower in adulthood than around the developmental 
switch. The in vivo situation resembles the in vitro data. KCC2 protein level first is up regulated and 
subsequent down regulated to a certain extent. The peak of protein expression thereby resides around 
P22 indicating that cultured cells develop faster. 
 
5.4. Altered expression of GlyR subunits and KCC2 upon blockade 
of glycinergic transmission 
Strychnine application is used for blockade of glycinergic transmission. It is known, that strych-
nine treatment of SN cultures directs large intracellular structures consisting of aggregated GlyR and 
gephyrin protein (Kirsch and Betz 1998). These structures presumably are endosomes. In this study, 
the contribution of GlyR activity to the subunit switch should be clarified. Continuous strychnine ap-
plication leads to a slight decrease in KCC2 expression compared to untreated cells. This indicates the 
GlyR to have a certain influence over KCC2 expression. In 2007, Fiumelli and Woodin reviewed, that 
the same happened upon chronic GABAAR blockade (Fiumelli and Woodin, 2007). The developmen-
tal up regulation of KCC2 failed to occur and the switch from excitatory to inhibitory was delayed. 
Dose-response studies demonstrate, that this effect reaches the significant level not until div 14. The 
use of 2 µM strychnine thereby leads to a 50% down regulation of KCC2 expression. Different proce-
dures are possibly responsible for the observed effect. First, GlyR activity is partly necessary for the 
developmental up regulation of KCC2 and hence changes of the ion ratio. This suggestion is supported 
by the fact, that the down regulation of KCC2 expression only is significant at div 14, being the criti-
cal time point for the developmental switch. This in turn would implicate that the influence of GlyR 
activity does not start until the transmission has become inhibitory. However, since no complete down 
regulation of KCC2 occurs, other factors like BDNF, EGR4 and CIP1 (Wenz et al. 2009, Fiumelli and 
Woodin 2007, Uvarov et al. 2006) might contribute and even are more deciding. Another possibility 
is, that GlyR activity impairs KCC2 turnover leading to more KCC2 protein to be removed from the 
membrane and degraded subsequently. As, until now still little is known about involvement of the 
GlyR in gene regulation, no precise prediction can be made. 
By further investigation, it should be clarified whether Ca2+-influx upon GlyR activity is responsi-
ble for changes in KCC2 expression. Blocking the entire neurotransmission in the SN cultures by TTX 
application indeed directs a 50% down regulation of KCC2 but also mAb7 signal confirming the data 
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obtained by strychnine application. Since BAPTA (able to bind the entire free Ca2+ in the culture) 
treatment also directs KCC2 down regulation, it becomes clear that Ca2+ may play a role in the regula-
tion of KCC2 expression. Interestingly, 408 signal, also representing gephyrin, was not altered. This 
might be explained by a putative specificity of mAb7 to phosphorylation states of gephyrin, which was 
not known until now. Thus, blockade of transmission and inhibition of Ca2+ signalling may influence 
the phosphorylation state of gephyrin, which in turn could be crucial for gephyrin scaffold formation. 
To simply block Ca2+ influx, cells were treated with the L-type Ca2+ channel blockers nifedipin 
and verapamil on the one hand and with the Ca2+ chelator EGTA, not being able to cross the cell 
membrane. Interestingly, no changes in KCC2 expression were obtained upon blocking L-type chan-
nels and no significant alterations appeared to the KCC2-monomer bands by catching all free-floating 
Ca2+ ions of the medium. However, two observations were quite clear: upon EGTA treatment, a 
prominent KCC2 oligomer band formed and mAb7 signal was abolished completely. This finding 
implicates that the absence of Ca2+ leads to closer or stronger KCC2 complexes. Thus, Ca2+ may help 
to loosen the complex. Without Ca2+, even SDS and urea cannot completely destroy the complexes. 
The phenomenon of the stronger KCC2 oligomer band was also observed in BAPTA-treated cells (not 
clearly visible in the presented immunoblot) but was not quantified. 
The described experiments show, that KCC2 expression, which is decreased by strychnine appli-
cation is not dependent on Ca2+-influx through L-type Ca2+ channels but on the Ca2+ being already 
inside the cell and somehow on GlyR activity. The latter might induce a still unknown signalling path-
way. KCC2 oligomer stability in turn is dependent on either the presence of Ca2+, on Ca2+ entering the 
cell via other than L-type channels such as R-, T-, N-, P- or Q-type Ca2+ channels or at last on Ca2+ 
being released from intracellular Ca2+ sources. Thus, Ca2+ is important for the decomposition ability of 
KCC2 complexes and the phosphorylation state of gephyrin. Thereby, Ca2+ is likely to mediate activa-
tion or inhibition of kinases and/or phosphatases respectively, which in turn regulate the phosphoryla-
tion states of KCC2 and gephyrin. Blockade of the entire transmission by TTX concerns KCC2 ex-
pression as well. This result is a combination of different blocked channels whereas GlyRs and AM-
PARs seem to play the most important role. 
The reciprocal assay, based on treating cells grown in glycine-free medium with glycine did not 
direct the expected contrary results namely an increase in KCC2 signal compared to untreated cells. 
Indeed a small increase in KCC2 expression is visible in treated cells at div 14 but this modification is 
unfortunately not significant. Since KCC2 signal is also developing in cells grown in glycine-free 
medium, the thought arises that GlyR activity is not essential for KCC2 expression, which is contrary 
to the results obtained before. More likely is the maybe inaccurate experimental approach. Perhaps 
glycine should have been applied for a longer time or in a higher concentration. Another aspect is that 
the glycine-free medium was not excluded to contain other GlyR agonists like -alanine or taurine. 
Two additional controls, being cells grown in regular NB++++ and treated with strychnine as well as 
cells grown in glycine-free NB++++ and treated with strychnine, would have shed light on the results. 
98 
Discussion 
5.5. Effects of KCC2 knockdown 
5.5.1. Design of shRNA sequences 
For the infection of neurons only lentiviral particles containing the kd2 oligo were used. This se-
quence exhibits the biggest success in the knockdown of recombinant KCC2 expression in HEK cells. 
KCC2kd2mm, a sequence similar to KCCkd2 but containing three mutations served as a potent non-
silencing control. Indeed, the trial to clone the mutated sequence of KCC2 (KCC2mut) into the viral 
vector pFSGW failed. This DNA fragment carries three silent mutations within the sequence that is 
targeted by KCC2kd2. Recombinantly expressed in neurons infected by KCC2kd2, KCC2mut is sup-
posed to rescue the knockdown effect. Unfortunately, it was not successful cloned into the lentiviral 
expression vector. Nevertheless, its robustness against the silencing construct was impressively dem-
onstrated in transfected HEK cells. 
 
5.5.2. Effects of KCC2-Knockdown in HCNs 
After confirming KCC2kd2 to be capable to induce an almost complete knock down of recombi-
nantly expressed KCC2 in a cell line system, it further is shown to also direct the down regulation of 
the endogenous protein. In HCNs, even 20 µl of the lentiviral suspension were sufficient to almost 
completely abolish endogenous KCC2 expression. Furthermore, mAb7 signal is dramatically reduced 
in cells infected with 80 µl virus suspension, indicating a correlation between KCC2 expression and 
the mentioned phosphorylation state of gephyrin. In contrast, 408 signal, also representing gephyrin 
protein is not altered. GlyRa subunits, represented by mAb4 also exhibit diminished expression. It 
would be interesting to find out whether decreased GlyRa subunit expression causes gephyrin down 
regulation or the other way around. Furthermore, it is possible, that both, GlyRa and gephyrin expres-
sion are impaired by the lack of KCC2, being independent on each other. 
 
5.5.3. Effects of KCC2 knockdown in SNs 
5.5.3.1. Semi-quantitative determination of protein levels on immunoblots 
KCC2 expression in SNs also is concerned by KCC2kd2. In a dose-dependent manner, KCC2 is 
down regulated according to increasing virus amounts. Similar to the situation in HCNs, GlyRa and 
gephyrin subunit expression is decreased upon higher virus amounts. In contrast, knockdown of KCC2 
evokes a significantly increased NMDAR expression. Whereas GlyRa2 expression is unchanged upon 
KCC2 knockdown, GlyRa1 subunit expression is significantly reduced in cells infected with the high-
est virus concentration. These findings suggest a model, in which cells lacking KCC2 remain in a ju-
venile state. They might miss the maturation caused by the activity of KCC2, being responsible for 
changing the ion ratio in wild type cells. Representative for a juvenile state would be a GlyRa2 expres-
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sion similar to control cells or even higher resembling younger neurons. Indeed, GlyRa2 expression 
remains unchanged, whereas the mature subunit, GlyRa1, is down regulated. The latter also suggests 
the cells, to reside in a juvenile state. As shown in immunoblots before, GlyRa2 protein level is not 
decreasing with time indicating KCC2 expression not to be crucial for regulating the juvenile GlyR 
form but rather being responsible for the maturation of the cell by exclusively modifying GlyRa1 ex-
pression. The latter might be a hint to the phenomenon, that GlyRa2 knockout mice do not exhibit the 
startle disease as seen in their GlyRa1 knockout counterparts. Possibly, GlyRa2 is not crucial for the 
maturation, but rather GlyRa1. Moreover, studies about a possible up regulation of the GlyRa1 subunit 
in GlyRa2 knockout mice still are lacking. It is not clear, whether the pure presence of KCC2 or rather 
its activity is sufficient for the GlyRa1 up regulation during development. If the activity of KCC2 is 
responsible for the successful expression of mature GlyRs, either the chloride level or the switch to a 
hyperpolarizing response upon channel opening may be crucial. This thesis is supported by the fact, 
that in mature cells Ca2+ signalling, which still arises in juvenile neurons upon depolarization, is no 
longer given. The other idea, in which the single presence of KCC2 is sufficient to induce expression 
of mature GlyRs might be supported by another study, demonstrating, that even inactive KCC2 is able 
to rescue a spine formation defect (Li et al. 2007). In their study, lack of KCC2 in cortical neurons 
directs immature spine morphology fitting with this study, in which lack of KCC2 leads to a juvenile 
phenotype of SNs regarding GlyR subunit expression. The increase in NMDAR expression in knock-
down cultures may reflect a compensating mechanism of the cells to augment the number of potential 
Ca2+-influx possibilities, which in turn are needed for a successful maturation. The depolarizations, 
being evoked by juvenile GlyRs, might therefore be crucial for an accumulation of Ca2+ within intra-
cellular stores. This Ca2+ then is needed for further maturation of the cell. Factors for the maturation 
might be the putative Ca2+-dependent stabilization of KCC2 oligomers or formation of gephyrin scaf-
folds. The latter would explain why BAPTA and continuous GlyR blockade induces KCC2 down 
regulation but not o/n application of EGTA and Ca2+ channel blockers. Furthermore, it might be fruit-
ful, to determine NMDAR expression in GlyRa2 knockout mice. It could be that, in order to compen-
sate for the loss of GlyRa2, NMDAR expression is up regulated, to ensure Ca2+ influx into the neurons 
in early development. 
 
5.5.3.2. Determination of receptor and KCC2 protein in control, mismatch and 
knockdown cultures 
The time course experiment sheds light on the development of the expression patterns of the ex-
amined proteins. KCC2 expression indeed is down regulated upon KCC2kd2 infection suggesting the 
sequence to operate properly. KCC2kd2mm in turn is not able to induce a knockdown of KCC2 ex-
pression. Even towards three weeks in culture, while the knockdown cells undergo a strong down 
regulation in KCC2 expression, mismatch cells do not exhibit significant changes in KCC2 expres-
sion. 
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GlyR subunits indeed are up regulated in SNs upon infection, but the changes are not significant. 
Cells, carrying the knockdown sequence, in turn undergo a slight decrease in mAb4 signal at div 15 
and even a significant diminishment of the latter at div 22. This is consistent with the data obtained in 
the experiments before (Figure 32). Unexpected was the initial augmentation of the mAb7 signal at 
div 8. Yet one week later, mAb7 signal is significantly depleted compared to control and mismatch 
cultures. Another week later, the expression is even stronger reduced. These data also are in line with 
earlier results. The increase of mAb7 expression at div 8 might result from the signals, still being too 
weak for an exact quantification. At none of the investigated time points, GlyRa2 and 408 signals were 
significantly altered upon KCC2 depletion. This indicates, as already shown before, that the juvenile 
subunit is not concerned by the lack of KCC2, and that antibody 408 labels another form of gephyrin 
than mAb7 recognizes, whereas expression of the former one is not concerned upon KCC2 down regu-
lation. Because mAb4 signal is altered upon KCC2kd2 infection but not GlyRa2 signal, expression of 
one of the adult subunits namely GlyRa1 or GlyRa3 has to be responsible therefore. As shown before 
GlyRa1 may be the subunit accounting for the changes in mAb4 signals. 
Important for the following studies, is finally that the mismatch construct is not able to induce sig-
nificant changes in the expression of the investigated proteins. Beside, it is remarkable that KCC2 
expression is slightly, albeit not significantly, up regulated. The same is true for mAb4 and mAb7 
signals, which in turn is consistent with the correlated down regulation of those three proteins. 
 
5.5.3.3. Localization of Immunoreactivities 
As expected, GFP positive (GFP+) cells, which contain the virus, show almost no KCC2 immuno-
reactivity when infected with the knockdown construct KCC2kd2, whereas they exhibit red immuno-
reactivity representing KCC2 signal when infected with the mismatch control KCC2kd2mm. It is also 
visible, that the total number of KCC2 positive cells is reduced in cultures infected with KCC2kd2. 
The described effect is present at all investigated div stages (div 15, 22 and 36). Thus, we could suc-
cessfully demonstrate that cells indeed are infected by lentiviral particles (GFP expression) and that 
infected cells exhibit a down regulation of KCC2 expression indicating our knockdown construct 
KCC2kd2 to work properly. 
After the confirming infection of the cells and the existence of a knockdown effect, GlyRa subunit 
expression was investigated using mAb4, which recognizes all GlyR α subunits. Thereby it turned out 
that the expression of the GlyR is concerned by KCC2kd2. At div 15, number of clusters, size of clus-
ters and the fluorescence intensity are significantly diminished upon KCC2 knockdown. This is also 
true for the two older stages div 22 and div 36. 
To discriminate between the juvenile and the adult GlyRa subunit, specific antibodies were used. 
MAb2 recognizes the adult form, whereas αGlyRa2 stains the juvenile subunit. First, the adult subunit, 
GlyRa1, was investigated. As immunoblots already suggested, the expression of GlyRa1 might be 
diminished upon KCC2 knockdown. Indeed, GlyRa1 expression exhibits a reduced expression in neu-
101 
Discussion 
rons infected with the knockdown construct. This is another indication for the cells to rest in a juvenile 
stage and not to augment GlyRa1 expression upon KCC2 knockdown. First, the number of GlyRa1 
puncta is diminished, indicating that less synapses containing the adult GlyR are formed. Secondly, 
the size of the clusters is smaller than in cells containing the mismatch construct. This points to a 
smaller active zone in KCC2 knockdown cultures. The reduction in the gray volume, representing the 
fluorescence intensity of the GlyRa1 clusters, suggests a smaller number of GlyRa1 receptors in the 
synapses. Since the cluster size is also diminished, the receptor density might not be affected. Indeed, 
the density of the receptors within the synapses was determined by dividing the gray value by the clus-
ter size. In no single case, a significant difference between mismatch and knockdown cultures was 
achieved. After three weeks in culture, the number of GlyRa1 clusters is reduced stronger than after 
two weeks. Towards five weeks in culture in turn, the effects become less strong. The gray value of 
GlyRa1 clusters even does not exhibit significant differences between mismatch and KCC2kd2 cul-
tures. The dilution of the effects upon a long time in culture might represent an upcoming compensa-
tion by the cells. In contrast, GlyRa2 expression is in most cases not concerned by the knockdown. 
The only parameter, which undergoes a significant change between knockdown and mismatch cells, is 
the number of clusters in div 22 neurons. It is not clear why the number of GlyRa2 clusters is reduced 
in knockdown cultures at the indicated time point. Obviously, there are less synapses containing the 
GlyRa2 subunits indicating that GlyRa2 also is concerned by the KCC2 knockdown but to a smaller 
extent than the adult receptor. In all other parameters no significant alterations between mismatch and 
knockdown cultures occur. This confirms the thesis that upon persisting in a juvenile stage the up 
regulation of GlyRa1 is reduced or completely left out. As expected, in mismatch cultures expression 
of the GlyR α subunits decreases from div 15 (eight clusters per 30 µm dendrite) to div 22 (22 clusters 
per 30 µm dendrite) representing the growing number of GlyRa containing synapses in the cell. Sur-
prisingly after three weeks in culture, the number of GlyRa clusters decreases in turn (12 clusters per 
30 µm dendrite). It is probable that after achieving adulthood, cells reduce the number of juvenile re-
ceptors. The same procedure is true for the expression of the GlyRa1 subunit suggesting the cell to 
remove receptors containing the adult subunit. However, it is also possible, that the turnover rate of 
the GlyR becomes decelerated in adulthood. Since mAb4 signal is stronger reduced than mAb2 signal, 
it might be that synapses containing the GlyRa3 subunit also are removed from the membrane and 
abolished. The GlyRa2 signal increases during the third week in culture and remains at eight puncta 
per 30 µm dendrite. In knockdown cells in turn, the number of GlyRa clusters is half of that of mis-
match cultures. In addition, an increase during the third week is remarkable as well as the decrease 
until div 36 but always exhibiting only half as many clusters as mismatch cells. This suggests that 
from begin of the measurement on less GlyRa clusters are present in knockdown cells but undergo as 
well as mismatch cells the mentioned alteration in their number during development. Thereby it is not 
clear which subunit causes the decrease in expression during the fifth week in culture because both, 
mAb2 and GlyRa2 signal even increase in that time period. 
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Since it was not clear so far why or how the reduction of GlyRa1 expression came, gephyrin as a 
GlyR anchoring protein was investigated as well. Thereby only mAb7 studies were performed because 
408 antibody was not achieved to give a useful immunoreactivity signal in my hands. Generally, the 
number of gephyrin puncta behaves similar to that of the GlyR. Starting with about six clusters per 
30 µm dendrite at div 15, the number of gephyrin clusters is quadruplicated during the following week 
but decreases until div 36 where it reaches about 17 clusters per 30 µm dendrite. The size of the 
puncta undergoes an analogue course. As already shown via immunoblots, the strongest reduction in 
mAb7 signal occurs around div 22, directly after the GlyR subunit switch is thought to take place. In 
knockdown cultures, the described rise and decline of gephyrin expression also occurs, but the number 
of clusters always remains significantly lower than in mismatch cells. The question arising from these 
results is, whether the reduction of gephyrin causes the loss of GlyR clusters or the other way around. 
Kling et al. postulate that GlyRa1 may be an important regulator of gephyrin accumulation because 
they found a drastic down regulation of gephyrin protein in membrane preparations of the spinal cord 
of GlyRa1 knockout mice (oscillator, Kling et al. 1997). Thus, the reduction of GlyRa1 might evoke 
the loss of gephyrin clusters. However, Kling et al. did not determine the gephyrin protein level of the 
whole cell. Therefore, it remains unclear whether gephyrin forms the large aggregates within the cyto-
plasm known from Kirsch and Betz (Kirsch and Betz 1998) or whether the overall gephyrin expres-
sion is reduced in their experiments. In this study, no intracellular gephyrin aggregates are formed 
upon KCC2 knockdown. This would suggest that reduced GlyRa1 expression directs a down regula-
tion of gephyrin. Regarding the results from Lévi et al., indicating that loss of gephyrin causes loss of 
GlyR clusters (Lévi et al. 2004) it is also possible, that the down regulation of gephyrin evokes a de-
crease in GlyRa1 expression. A last but also probable presumption could be that KCC2 down regula-
tion is responsible for both GlyRa1 and gephyrin reduction. This would indicate that the absence of 
KCC2 protein or the predicted high chloride level in the cells respectively is able to regulate GlyRa1 
and/or gephyrin expression. From div 22 on, the fluorescence intensity and from div 36 on also the 
size of the gephyrin clusters respectively are no longer significantly reduced. The same was already 
seen for GlyRa1 clusters indicating an upcoming, compensatory effect in the infected neurons. 
In 2007, Li et al. demonstrated KCC2 to be crucial for spine development. They show abnormal 
dendritic spine morphologies in KCC2-/- cortical neuronal cultures. These spines exhibit a filopodia-
like morphology and significantly longer protrusions compared to control cells (Li et al. 2007). The 
same phenomenon was observed but not analyzed in infected cells. Figure 48B and Figure 49B clearly 
demonstrate the altered protrusion morphology. During the study, I could observe more branched den-
drites and longer spines in most neurons infected with KCC2kd2. These findings support Li’s data on 
the one hand and on the other hand, the thesis that loss of KCC2 keeps the neurons back in a juvenile 
state. Another noticeable characteristic of the knockdown cells is that they appear smaller than the 
mismatch controls also supporting the latter. 
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To characterize further effects initiated by KCC2 knockdown, other synaptic markers were ana-
lyzed. One of them is PSD 95. Important for the study was, that PSD 95 is not shown to interact with 
gephyrin and/or the GlyR. PSD 95 has an anchoring function for AMPAR and NMDAR. Thus, synap-
tic components independent from the GlyR-gephyrin complex were analyzed for alterations. At 
div 15, the number of PSD 95 puncta accounts about six per 30 µm dendrite. During the next week, 
this value is more than duplicated and does not drop later on. The size of the PSD 95 clusters in turn 
behaves as that of the GlyR and gephyrin: it rises between div 15 and div 22 and declines until div 36. 
At no point in time, the measured values differ to significant extents. The high standard deviations of 
especially the knockdown cultures are a sign of a broad expression variability of PSD 95. In Li’s 
study, the number of PSD 95 puncta was reduced in KCC2-/- neurons being not true for my study. Li et 
al also showed that the observed effect was not dependent on the function of KCC2 but probably on its 
interaction with the cytoskeleton. For my work, the latter imports that either loss of KCC2 function 
results in a juvenile chloride concentration within the cell or that loss of KCC2 in general gives rise to 
complex cytoskeletal alterations. The latter might suggest a mechanism in which KCC2 regulates 
gephyrin expression via complicate cytoskeletal interactions. 
The next step was to explore the expression of GABAAR being another receptor to mediate inhibi-
tory transmission. A first but not measured observation was that cells carrying GABAAR immunoreac-
tivity did not exhibit differences in size. In contrast, knockdown cells positive for the GlyR or gephy-
rin appear to be smaller than their mismatch counterparts. The number of GABAAR puncta undergoes 
the same course as GlyRa1. The number of clusters rises between div 15 and div 22 and subsequently 
declines. The same happens to the size of GABAAR clusters. Except for the number of clusters at 
div 36, no significant differences occur in GABAAR expression comparing mismatch and knockdown 
cultures. It might be that GABAAR in general is less sensitive to KCC2 down regulation in SNs be-
cause it is not the main inhibitory receptor expressed. However, being confronted with the silencing 
construct for more than four weeks, even GABAAR receptor expression may be concerned. In sum-
mary, the effect onto the GABAAR remains mild or even is not present at all. This indicates GABAAR 
being not concerned because it fails to bind gephyrin. The latter hypothesis is postulated by Poulopou-
los who found no direct interaction between gephyrin and the GABAAR (Poulopoulos et al. 2009). 
Furthermore, this thesis would support the earlier idea of KCC2 knockdown to induce gephyrin down 
regulation, which in turn affects GlyR expression. Moreover, these results indicate, that GABAAR 
does not compensate for the reduction in GlyRa1 expression 
The last synaptic component, which has been examined in the present study, was the expression of 
the presynaptically localized vesicular inhibitory amino acid transporter (VIAAT). During the investi-
gated time period, the number of VIAAT puncta was triplicated and the size of the clusters was almost 
duplicated. At div 36, it was no longer possible to measure these parameters because the VIAAT sig-
nal became to strong and hence unclear. However, no significant changes of the critical parameters 
occurred suggesting the presynapse to remain completely untouched by KCC2 knockdown. 
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As already mentioned, for all immunoreactivities and all time points, the quotient of the “gray 
value” and the “size” of the puncta was generated. Since the obtained data did not exhibit significant 
changes, they are not shown in the thesis. The conclusion is that the density of the single receptors 
within the puncta is not altered at all. 
 
In summary, by means of the PCR data, a switch in the mRNA expression of the juvenile GlyRa2 
and the adult GlyRa1 subunit can be determined around div 14. To the same time point, KCC2 protein 
and RNA expression reaches a maximum in vitro and in vivo suggesting a possible linkage of KCC2 
and the GlyR expression and/or activity. Furthermore, KCC2 expression and stability might be de-
pendent on GlyR activity, evoking Ca2+ influx or on Ca2+ presence in general. Thereby, Ca2+ might 
play a role in regulating kinase or phosphatase activity, which in turn modifies the phosphorylation 
state of KCC2 and/or gephyrin. The fact, that phosphorylation states indeed are altered upon applica-
tion of the mentioned inhibitors and chelators is supported by the absence of mAb7 and PS-6 signal in 
treated cultures. However, the other way around, suppression of KCC2 protein expression clearly di-
rects down regulation of the adult GlyR alpha subunit and gephyrin without affecting the expression of 
other synaptic proteins like e.g. GABAAR or VIAAT. 
In conclusion, the results indicate a complex correlation of KCC2 and the GlyR, rather GlyRa1, 
which are supposed to be dependent on each other to a certain extent. First, KCC2 expression, activity 
or maybe localization in the membrane is dependent on GlyR activity. Activation of the latter induces 
a depolarization of the cell and the subsequent Ca2+ influx into the cell. Ca2+ in turn is able to evoke 
kinase- or phosphatase-determined alteration in the phosphorylation state of KCC2. KCC2 achieves a 
more or less stable conformation dependent on its phosphorylation state, which again is important for 
its activity. On the other hand, an almost complete knockdown of KCC2 expression in cultured spinal 
neurons alters the expression of GlyRa1 and the scaffolding protein gephyrin, which is connected to 
the adult form of the GlyR. Either the presence of a high chloride level inhibits GlyRa1 expression in 
any way, so that the maturation of the cell is initiated by a decreasing intracellular chloride level, or 
the presence of KCC2 has an influence onto GlyRa1 expression via the cytoskeleton. This is also 
probable since it was already shown that KCC2 owns binding sites for cytoskeletal proteins, which yet 
are different from the cytoskeletal proteins, gephyrin is able to bind. Nevertheless, it is possible, that 
unknown connections among cytoskeletal proteins, KCC2, gephyrin and the GlyR facilitate the de-
scribed regulation. It also is possible that the adult GlyR is not allowed to be anchored to the cy-
toskeleton at synaptic sites caused by the reduction of gephyrin upon KCC2 knockdown. Subse-
quently, the GlyR molecules are removed from the membrane and degraded within the cell. Unfortu-
nately, the level of the GlyRb subunit could not be determined. This would have shed light to the latter 
question, because when removed from the membrane, the whole GlyR pentamer including the GlyRb 
subunits would be concerned. A last probability is that the reduction in GlyRa1 expression results 
from transcriptional regulation. 
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A probable model could be that the activity of the juvenile GlyR, triggering an excitatory re-
sponse, is needed for accumulation of Ca2+ within intracellular stores. Ca2+ in turn is somehow respon-
sible for the successful work, the stability or the phosphorylation state of KCC2. KCC2 subsequently, 
changes the ion ratios within the cell, which in turn directs maturation of the cell in terms of increased 
gephyrin and/or GlyRa1 expression. 
 
 6. Future aspects 
My work evokes more questions than it could answer. Initiated by the results of the treatments, the 
question came up which role Ca2+ is playing in stabilizing the KCC2 tetramer and thereby its ability to 
transport ions. In collaboration with a physiologically arranged research group, the activity of KCC2 
could be investigated using specific blockers for KCC2 or measuring Rb+ uptake by the cells follow-
ing the described treatments. This could shed light on whether Ca2+ is able to alter KCC2 activity via 
destabilization of the complex. Furthermore, it has to be clarified if KCC2 indeed is phosphorylated or 
dephosphorylated upon Ca2+ influx or presence. Cloning experiments to identify possible phosphoryla-
tion sites as well as treatment with specific kinase and phosphatase inhibitors may help to answer the 
latter. 
For the glycine treatments, more controls are needed such as cells grown in NB++++ but treated 
with strychnine as well as cells grown in glycine-free NB++++ also treated with strychnine. This would 
better mimic the silent GlyR. 
Additional to the mismatch shRNA, a rescue construct should have been adapted. However, I was 
not able to clone the mutated KCC2 sequence into the lentiviral vector. The collaboration with a 
versed molecular biology research group may result in a functional rescue control. Cells transduced by 
both, the knockdown and the rescue construct should no longer exhibit the effects evoked by KCC2 
knockdown. Moreover, switching off the TrkB receptor (receptor for BDNF) by RNAi or specific 
inhibitors, might direct the same effects than the KCC2 knockdown. Additionally, other components 
of the KCC2 signalling pathway or KCC2 regulators should be investigated. An early overexpression 
of KCC2 in cultured neurons may lead to the opposite effect, consisting of an early onset of GlyRa1 
up regulation. In addition, the low, mature chloride level and therewith the hyperpolarizing transmis-
sion state should be achieved earlier in development. 
A functionally inactive form of KCC2 transfected or transduced to the SNs may give information 
about the dependence of the GlyRa1 expression on KCC2 activity. 
Further insights in the association of KCC2 and the GlyR may be achieved by investigating KCC2 
knockout animals. KCC2 knockout mice as well as conditional knockout mice already are available at 
the moment. Cross-sections of the spinal cord from knockout animals should be taken and analyzed 
for GlyR subunit and gephyrin immunoreactivities. The results should be compared to wild type ani-
mals and the results of this thesis. The consequential issues might show whether the expression of the 
adult GlyR alpha1 subunit also is down regulated in knockout mice. Possibly, some compensatory 
effects would be observed as well. 
In terms of knockout animals, also the GlyRa2 knockout mouse should be examined. The GlyRa2 
knockout mouse might exhibit an up regulation in either another than the GlyRa2 subunit or even in 
NMDAR to compensate for the loss of the alpha2 subunit. 
107 
Future aspects 
108 
Furthermore, the silencing sequence could be injected to the spinal cord of newborn rats, which 
might be analyzed two ore more weeks later. Therefore, cross-sections of the spinal cord should be 
investigated for GlyR subunit and gephyrin immunoreactivity as well. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 7. Abbreviations 
CT Difference of the CT-values of the control an the investigated gene 
AMPAR α-Amino-3-hydroxy-5-methyl-4-isoxazol-Propionic acid receptor 
APS Ammoniumpersulfate 
APV Amino-Phosphonopentanoate 
AraC Cytarabin 
BDNF Brain derived neurothrophic factor 
bp Basepairs 
BSA  Bovine serum albumin 
CaCl2 Calciumdichloride 
cDNA Copy DNA 
CT Cycle Threshold (cycle of the RTq-PCR, in which the enzyme-substrate curve 
changes from the linear to the Plateau-phase) 
DABCO 1,4-Diazabicyclo[2.2.2]octan 
div Days in vitro 
Dk Donkey 
DMEM Dulbecco’s modified Eagle Medium 
DMSO Dimethylsulfoxide 
dNTP Deoxyribonucleotide-Triphosphate 
DOC Sodium Deoxycholate 
ds Double stranded 
E Embryonic day 
ECL Enhanced Chemiluminescence 
EDTA Ethylendiamine-tetraacetate 
EGFP Enhanced green fluorescent protein 
et al. et alteri 
EtBr Ethidiumbromide 
EtOH Ethanol 
FBS/FCS Fetal bovine/calf serum 
GABAAR γ-Aminobutteric Acid A-Receptor 
GFP Green fluorescent protein 
GlyR Glycine receptor 
GlyT2 Glycine transporter subtype 2 
gpig Guinea pig 
gt Goat 
HBSS Hanks balanced salt solution 
HCN Hippocampal neuron/hippocampal neuronal 
HEK Human embryonic kidney 
HRP  Horse raddish peroxidase 
HS Horse Serum 
IB Immunoblot 
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IR Immunoreactivity 
KCC2 Potassium chloride cotransporter 2 
kd Knockdown 
KOH Potassiumydroxide 
LB Luria-Bertani 
M Mol per litre 
mA Milliampere 
MAP Microtubule associated protein 
MCS Multiple cloning site 
MEF Mouse embryonic fibroblast 
MeOH Methanol 
MgCl2 Magnesiumdichloride 
Milli-Q Double distilled water 
mIPSC Miniature inhibitory postsynaptic current 
mm mismatch 
mM Millimol per litre 
MnCl2 Mangandichloride 
ms Mouse 
n.s. Not significant 
NB Neurobasal 
NL Neuroligin 
NMDAR N-Methyl-D-Aspartate receptor 
o/d Over day 
o/n Over night 
OD Optical density 
P Postnatal day 
P/S Penicillin/Streptomycin 
PAGE Polyacrylamide gelelectrophoresis 
PBS Phosphate buffered saline 
PET Polyethylenterephthalate 
PFA Paraformaldehyde 
pH Potentia hydrogenii (cologarithm of the activity of dissolved hydrogen ions) 
PIPES Piperazine-1,2-bis[2-ethanesulfonic acid] 
PMSF Phenylmethylsulphonylfluoride 
pS picoSiemens 
PSD 95 Postsynaptic Density Protein 95 
PVDF Polyvinylidenfluoride 
rb Rabbit 
RIPA Radio immunoprecipitation assay 
RNAi RNA interference 
rpm Rounds per minute 
RT Room temperature 
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RT-PCR Reverse Transcriptase Polymerase chain reaction) 
RTq-PCR Real Time quantitative PCR 
s.d. Standard deviation 
S2 Safety-Level 2 
SDS Sodiumdodecylsulfate 
shRNA short hairpin RNA 
SN Spinal neuron/spinal neuronal 
SOB Super optimal broth 
sp Sheep 
SW Swing-out rotor  
TBS Tris-buffered saline 
TBS-T Tris-buffered saline + Tween-20  
TEMED N,N,N',N'-Tetramethylethylenediamine 
Tris Trimethylsilylsilan 
TWEEN-20 Polyoxyethylen(20)-sorbitan-monolaurate 
UT Untransfected 
UZ Ultrazentrifugation/Ultrazentrifuge 
V Volt 
VIAAT Vesicular Inhibitory Amino Acid Transporter 
Wnt Wingless (wg) Integrated (Int) 
xg X-times acceleration of gravitiy 
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